References - Endocrinology
^ Mathews, CK and van Holde, K. E. (1990). "Integration and control of metabolic processes". in Bowen, D.. Biochemistry. The Benjamin/Cummings publishing group. pp. 790–792. ISBN 0-8053-5015-2. OCLC 20352437.
· ^ Beato M, Chavez S and Truss M (1996). "Transcriptional regulation by steroid hormones". Steroids 61 (4): 240–251. doi:10.1016/0039-128X(96)00030-X. PMID 8733009.
· ^ Hammes SR (2003). "The further redefining of steroid-mediated signaling". Proc Natl Acad Sci USA 100 (5): 21680–2170. doi:10.1073/pnas.0530224100. PMID 12606724.
· ^ Collier, Judith. et.al (2006). Oxford Handbook of Clinical Specialties 7th edn.. Oxford. pp. 350–1. ISBN 0-19-853085-4.
· ^ University of Virginia - HISTOLOGY OF THE ENDOCRINE GLANDS
· ^ Kasper et al. (2005). Harrison's Principles of Internal Medicine. McGraw Hill. pp. 2074. ISBN 0-07-139140-1.
· ^ Bhowmick NA, Chytil A, Plieth D, et al (February 2004). "TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia". Science 303 (5659): 848–51. doi:10.1126/science.1090922. PMID 14764882.
· ^ a b Kosfeld M, Heinrichs M, Zak PJ, Fischbacher U, Fehr E (June 2005). "Oxytocin increases trust in humans" ([dead link] – Scholar search). Nature 435 (7042): 673–6. doi:10.1038/nature03701. PMID 15931222. http://www.iew.unizh.ch/home/kosfeld/papers/ottrust_nature.pdf.
· ^ a b Kraft U (Jun/July 2007). "Rhythm and Blues". Scientific American Mind. http://www.sciamdigital.com/index.cfm?fa=Products.ViewIssuePreview&ARTICLEID_CHAR=C001082B-2B35-221B-641CA6ED64E8BCF3.
· ^ a b c Kaushansky K (May 2006). "Lineage-specific hematopoietic growth factors". N Engl J Med. 354 (19): 2034–45. doi:10.1056/NEJMra052706. PMID 16687716.
· ^ Frühbeck G (July 2004). "The adipose tissue as a source of vasoactive factors". Curr Med Chem Cardiovasc Hematol Agents 2 (3): 197–208. doi:10.2174/1568016043356255. PMID 15320786. http://openurl.ingenta.com/content/nlm?genre=article&issn=1568-0169&volume=2&issue=3&spage=197&aulast=Frühbeck.
· ^ Colorado State University - Biomedical Hypertextbooks - Somatostatin
· ^ Endo K, Matsumoto T, Kobayashi T, Kasuya Y, Kamata K (February 2005). "Diabetes-related changes in contractile responses of stomach fundus to endothelin-1 in streptozotocin-induced diabetic rats" ([dead link] – Scholar search). J Smooth Muscle Res 41 (1): 35–47. doi:10.1540/jsmr.41.35. PMID 15855738. http://joi.jlc.jst.go.jp/JST.JSTAGE/jsmr/41.35?from=PubMed.
· ^ a b Physiology at MCG 5/5ch4/s5ch4_17
· ^ Pentikäinen V, Erkkilä K, Suomalainen L, Parvinen M, Dunkel L (May 2000). "Estradiol acts as a germ cell survival factor in the human testis in vitro". J Clin Endocrinol Metab. 85 (5): 2057–67. doi:10.1210/jc.85.5.2057. PMID 10843196. http://jcem.endojournals.org/cgi/pmidlookup?view=long&pmid=10843196.
· ^ a b c d Placental Hormones
· ^ Physiology at MCG 5/5ch9/s5ch9_13
· ^ Hould F, Fried G, Fazekas A, Tremblay S, Mersereau W (1988). "Progesterone receptors regulate gallbladder motility". J Surg Res 45 (6): 505–12. doi:10.1016/0022-4804(88)90137-0. PMID 3184927.
· ^ Hormonal Therapy
· ^ Massaro D, Massaro GD (2004). "Estrogen regulates pulmonary alveolar formation, loss, and regeneration in mice". American Journal of Physiology. Lung Cellular and Molecular Physiology 287 (6): L1154–9. doi:10.1152/ajplung.00228.2004. PMID 15298854.
http://en.wikipedia.org/wiki/Antithyroid_agents
http://en.wikipedia.org/wiki/Thyroidectomy
^ http://www.merck.com/mmhe/sec13/ch162/ch162e.html Acromegaly and Gigantism
^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0721629210.
^ Baseball's Steroid Era
^ "Andre the Giant: Bio". WWE.com. http://www.wwe.com/superstars/halloffame/andrethegiant/bio/. Retrieved on 2007-10-16.
^ "André the Giant official website.". http://www.andrethegiant.com/. Retrieved on 2007-07-08.
^ [1]
^ http://www.barrybrown.info/unsungheroes/rondohatton.html
^ BBC News report on Punch and Acromegaly
^ Login IS, Login J (July 2008). "Governor Pio Pico, the monster of California...no more: lessons in neuroendocrinology". Pituitary. doi:10.1007/s11102-008-0127-1. PMID 18597174. Open Access; http://www.springerlink.com/content/u7645787h2435373/fulltext.pdf
^ Nawar RN, AbdelMannan D, Selman WR, Arafah BM (2008). "Pituitary tumor apoplexy: a review". J Intensive Care Med 23 (2): 75–90. doi:10.1177/0885066607312992. PMID 18372348.
Endocrine and Metabolic Diseases Information Service
· ^ a b c Eileen K. Corrigan (2007). "Adrenal Insufficiency (Secondary Addison's or Addison's Disease)". NIH Publication No. 90-3054. http://www.pituitary.org/disorders/addisons_disease.aspx.
· ^ MeSH Adrenal+Insufficiency
· ^ Ten S, New M, Maclaren N (2001). "Clinical review 130: Addison's disease 2001". J. Clin. Endocrinol. Metab. 86 (7): 2909–22. doi:10.1210/jc.86.7.2909. PMID 12899587. http://jcem.endojournals.org/cgi/content/full/86/7/2909.
· ^ a b c d e f g Ashley B. Grossman, MD (2007). "Addison's Disease". Adrenal Gland Disorders. http://www.merck.com/mmhe/sec13/ch164/ch164b.html.
· ^ Brender E, Lynm C, Glass RM (2005). "JAMA patient page. Adrenal insufficiency". JAMA 294 (19): 2528. doi:10.1001/jama.294.19.2528. PMID 16287965. http://jama.ama-assn.org/cgi/content/full/294/19/2528.
· ^ "Dorlands Medical Dictionary:adrenal insufficiency". http://www.mercksource.com/pp/us/cns/cns_hl_dorlands_split.jsp?pg=/ppdocs/us/common/dorlands/dorland/four/000053970.htm.
· ^ "Secondary Adrenal Insufficiency: Adrenal Disorders: Merck Manual Professional". http://www.merck.com/mmpe/sec12/ch153/ch153c.html.
· ^ "hypopituitary". 2006. http://www.webmd.com/a-to-z-guides/hypopituitary.
· ^ Thomas A Wilson, MD (2007). "Adrenal Insufficiency". Adrenal Gland Disorders. http://www.emedicine.com/PED/topic47.htm.
· ^ Thomas A Wilson, MD (1999). Adrenoleukodystrophy. http://healthlink.mcw.edu/article/921176192.html.
· ^ "Diabetes Blue Circle Symbol". International Diabetes Federation. 17 March 2006. http://www.diabetesbluecircle.org.
· ^ L M Tierney, S J McPhee, M A Papadakis (2002). Current medical Diagnosis & Treatment. International edition. New York: Lange Medical Books/McGraw-Hill. pp. 1203–1215. ISBN 0-07-137688-7.
· ^ a b c Rother, KI (2007). "Diabetes Treatment — Bridging the Divide". N Engl J Med 356 (15): 1499–1501. doi:10.1056/NEJMp078030. PMID 17429082. http://content.nejm.org/cgi/content/full/356/15/1499.
· ^ a b c World Health Organisation Department of Noncommunicable Disease Surveillance (1999). "Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications" (PDF). http://whqlibdoc.who.int/hq/1999/WHO_NCD_NCS_99.2.pdf.
· ^ Mailloux, Lionel (2007-02-13). "UpToDate Dialysis in diabetic nephropathy". UpToDate. http://patients.uptodate.com/topic.asp?file=dialysis/15147. Retrieved on 2007-12-07.
· ^ "Other "types" of diabetes". American Diabetes Association. August 25, 2005. http://www.diabetes.org/other-types.jsp.
· ^ "Diseases: Johns Hopkins Autoimmune Disease Research Center". http://autoimmune.pathology.jhmi.edu/diseases.cfm?systemID=3&DiseaseID=23. Retrieved on 2007-09-23.
· ^ "FDA Approves First Ever Inhaled Insulin Combination Product for Treatment of Diabetes". http://www.fda.gov/bbs/topics/news/2006/NEW01304.html. Retrieved on 2007-09-09.
· ^ "MannKind Unveils Proposed Trade Name at Dedication of Danbury Manufacturing Facility". http://www.mannkindcorp.com/pressreleasetext.aspx?releaseID=1198182. Retrieved on 2008-10-23.
· ^ Baillie, K (2008-07-05). "ClinicLog article on current diabetes trials.". ClinicLog.com. http://www.cliniclog.com/type_1_diabetes_trials.php. Retrieved on 2008-07-23.
· ^ Eberhart, MS; Ogden C, Engelgau M, Cadwell B, Hedley AA, Saydah SH (19 November 2004). "Prevalence of Overweight and Obesity Among Adults with Diagnosed Diabetes --- United States, 1988--1994 and 1999--2002". Morbidity and Mortality Weekly Report (Centers for Disease Control and Prevention) 53 (45): 1066–1068. http://www.cdc.gov/mmwR/preview/mmwrhtml/mm5345a2.htm. Retrieved on 2007-03-11.
· ^ Arlan Rosenbloom, Janet H Silverstein (2003). Type 2 Diabetes in Children and Adolescents: A Clinician's Guide to Diagnosis, Epidemiology, Pathogenesis, Prevention, and Treatment. American Diabetes Association,U.S.. pp. 1. ISBN 978-1580401555.
· ^ Lang, Iain A.; Tamara S. Galloway, Alan Scarlett, William E. Henley, Michael Depledge, Robert B. Wallace, and David Melzer (2008). "Association of Urinary Bisphenol A Concentration with Medical Disorders and Laboratory Abnormalities in Adults". Journal of the American Medical Association 300 (1): 1303–1310. doi:10.1001/jama.300.11.1303.
· ^ "Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group". Lancet 352 (9131): 854–65. 1998. doi:10.1016/S0140-6736(98)07037-8. PMID 9742977.
· ^ Lawrence JM, Contreras R, Chen W, Sacks DA (May 2008). "Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999-2005". Diabetes Care 31 (5): 899–904. doi:10.2337/dc07-2345. PMID 18223030.
· ^ Lyssenko, V. (2008). "Clinical risk factors, DNA variants, and the development of type 2 diabetes". N Engl J Med 359 (21): 2220–2232. doi:10.1056/NEJMoa0801869. http://content.nejm.org/cgi/content/short/359/21/2220?query=TOC.
· ^ Walley AJ, Blakemore AI, Froguel P (2006). "Genetics of obesity and the prediction of risk for health". Hum. Mol. Genet. 15 Spec No 2: R124–30. doi:10.1093/hmg/ddl215. PMID 16987875.
· ^ "Monogenic Forms of Diabetes: Neonatal Diabetes Mellitus and Maturity-onset Diabetes of the Young". National Diabetes Information Clearinghouse (NDIC) (National Institute of Diabetes and Digestive and Kidney Diseases, NIH). http://www.diabetes.niddk.nih.gov/dm/pubs/mody/. Retrieved on 2008-08-04.
· ^ Barrett TG (2001). "Mitochondrial diabetes, DIDMOAD and other inherited diabetes syndromes". Best Pract. Res. Clin. Endocrinol. Metab. 15 (3): 325–43. doi:10.1053/beem.2001.0149. PMID 11554774.
· ^ Santaguida PL, Balion C, Hunt D, Morrison K, Gerstein H, Raina P, Booker L, Yazdi H. "Diagnosis, Prognosis, and Treatment of Impaired Glucose Tolerance and Impaired Fasting Glucose". Summary of Evidence Report/Technology Assessment, No. 128. Agency for Healthcare Research and Quality. http://www.ahrq.gov/clinic/epcsums/impglusum.htm. Retrieved on 2008-07-20.
· ^ Sniderman, AD; Bhopal R, Prabhakaran D, Sarrafzadegan N, Tchernof A (2007). "Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis". International journal of epidemiology 36 (1): 220–225. doi:10.1093/ije/dyl245. PMID 17510078.
· ^ Genuth S (Jan-Feb 2006). "Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes". Endocr Pract 12 (Suppl 1): 34–41. ISSN 1530-891X. PMID 16627378.
· ^ Lee CM, Huxley RR, Lam TH, Martiniuk AL, Ueshema H, Pan WH, Welborn T, Woodward M; Asia Pacific Cohort Studies Collaboration (2007). "Prevalence of diabetes mellitus and population attributable fractions for coronary heart disease and stroke mortality in the WHO South-East Asia and Western Pacific regions". Asia Pac J Clin Nutr 16 (1): 187–92. PMID 17215197.
· ^ Seidell JC (2000). "Obesity, insulin resistance and diabetes--a worldwide epidemic". Br. J. Nutr. 83 Suppl 1: S5–8. PMID 10889785.
· ^ Daneman D (2006). "Type 1 diabetes". Lancet 367 (9513): 847–58. doi:10.1016/S0140-6736(06)68341-4. PMID 16530579.
· ^ Borch-Johnsen K, Joner G, Mandrup-Poulsen T, Christy M, Zachau-Christiansen B, Kastrup K, Nerup J (1984). "Relation between breast-feeding and incidence rates of insulin-dependent diabetes mellitus. A hypothesis". Lancet 2 (8411): 1083–6. doi:10.1016/S0140-6736(84)91517-4. PMID 6150150.
· ^ Naim Shehadeh, Raanan Shamir, Moshe Berant, Amos Etzioni (2001). "Insulin in human milk and the prevention of type 1 diabetes". Pediatric Diabetes 2 (4): 175–177. doi:10.1034/j.1399-5448.2001.20406.x. http://www.blackwell-synergy.com/doi/abs/10.1034/j.1399-5448.2001.20406.x?journalCode=pdi.
· ^ Virtanen S, Knip M (2003). "Nutritional risk predictors of beta cell autoimmunity and type 1 diabetes at a young age". Am J Clin Nutr 78 (6): 1053–67. PMID 14668264.
· ^ Hyppönen E, Läärä E, Reunanen A, Järvelin MR, Virtanen SM (2001). "Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study". Lancet 358: 1500. doi:10.1016/S0140-6736(01)06580-1. PMID 11705562.
· ^ Elliott RB, Pilcher CC, Fergusson DM, Stewart AW (Sep-Oct 1996). "A population based strategy to prevent insulin-dependent diabetes using nicotinamide". J. Pediatr. Endocrinol. Metab. 9 (5): 501–9. PMID 8961125.
· ^ Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson J, Hemiö K, Hämäläinen H, Härkönen P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Paturi M, Sundvall J, Valle T, Uusitupa M, Tuomilehto J (2006). "Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study". Lancet 368 (9548): 1673–9. doi:10.1016/S0140-6736(06)69701-8. PMID 17098085.
· ^ a b Knowler W, Barrett-Connor E, Fowler S, Hamman R, Lachin J, Walker E, Nathan D (2002). "Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin". N Engl J Med 346 (6): 393–403. doi:10.1056/NEJMoa012512. PMID 11832527.
· ^ Bantle JP, Wylie-Rosett J, Albright AL, et al (2006). "Nutrition recommendations and interventions for diabetes--2006: a position statement of the American Diabetes Association". Diabetes Care 29 (9): 2140–57. doi:10.2337/dc06-9914. PMID 16936169. http://care.diabetesjournals.org/cgi/content/full/29/9/2140.
· ^ Gerstein H, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, Hanefeld M, Hoogwerf B, Laakso M, Mohan V, Shaw J, Zinman B, Holman R (2006). "Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial". Lancet 368 (9541): 1096–105. doi:10.1016/S0140-6736(06)69420-8. PMID 16997664.
· ^ Kjeldsen SE, Julius S, Mancia G, McInnes GT, Hua T, Weber MA, Coca A, Ekman S, Girerd X, Jamerson K, Larochelle P, Macdonald TM, Schmieder RE, Schork MA, Stolt P, Viskoper R, Widimsky J, Zanchetti A; for the VALUE Trial Investigators (2006). "Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial". J Hypertens 24 (7): 1405–1412. doi:10.1097/01.hjh.0000234122.55895.5b. PMID 16794491.
· ^ Wasko MC, Hubert HB, Lingala VB, et al (2007). "Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis". JAMA 298 (2): 187–93. doi:10.1001/jama.298.2.187. PMID 17622600.
· ^ Stuebe AM, Rich-Edwards JW, Willett WC, Manson JE, Michels KB (2005). "Duration of lactation and incidence of type 2 diabetes". JAMA 294 (20): 2601–10. doi:10.1001/jama.294.20.2601. PMID 16304074.
· ^ Adler, A.I.; Stratton, I. M.; Neil, H.A.; et al (2000). "Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study". BMJ 321 (7258): 412–419. doi:10.1136/bmj.321.7258.412. PMID 10938049. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=27454&rendertype=abstract.
· ^ a b c Vinik AI, Fishwick DT, Pittenger G (2004). "Advances in diabetes for the millennium: toward a cure for diabetes". MedGenMed : Medscape general medicine 6 (3 Suppl): 12. PMID 15647717.
· ^ Stratta RJ, Alloway RR. (1998). "Pancreas transplantation for diabetes mellitus: a guide to recipient selection and optimum immunosuppression". BioDrugs. 10 (5): 347–357. doi:10.2165/00063030-199810050-00002. PMID 18020607.
· ^ Shapiro AM, Ricordi C, Hering BJ, et al (2006). "International trial of the Edmonton protocol for islet transplantation". N. Engl. J. Med. 355 (13): 1318–30. doi:10.1056/NEJMoa061267. PMID 17005949.
· ^ Voltarelli, JC; Couri CE, Stracieri AB, Oliveira MC, Moraes DA, Pieroni F, Coutinho M, Malmegrim KC, Foss-Freitas MC, Simoes BP, Foss MC, Squiers E, Burt RK. (2007). "Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus". JAMA 297 (14): 1568–76. doi:10.1001/jama.297.14.1568. PMID 17426276. http://jama.ama-assn.org/cgi/content/full/297/14/1568.
· ^ Rubino, F; Gagner M (2002). "Potential of surgery for curing type 2 diabetes mellitus". Ann. Surg. 236 (5): 554–9. doi:10.1097/00000658-200211000-00003. PMID 12409659.
· ^ Adams, TD; Gress RE, SmithSC, et al (2007). "Long-term mortality after gastric bypass surgery". N. Engl. J. Med. 357 (8): 753–61. doi:10.1056/NEJMoa066603. PMID 17715409.
· ^ Cohen, RV; SchiavonCA, Pinheiro JS, Correa JL, Rubino F (2007). "Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases". Surg Obes Relat Dis. 3 (2): 195–7. doi:10.1016/j.soard.2007.01.009. PMID 17386401.
· ^ Vasonconcelos, Alberto (2007-09-01). "Could type 2 diabetes be reversed using surgery?". New Scientist (2619): 11–13. http://www.newscientist.com/channel/health/mg19526193.100-could-type-2-diabetes-be-reversed-using-surgery.html. Retrieved on 2007-09-26.
· ^ Nathan, D.M.; Cleary P.A., Backlund J.Y., et al (2005). "Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes". N. Engl. J. Med. 353 (25): 2643–53. doi:10.1056/NEJMoa052187. PMID 16371630.
· ^ The Diabetes Control and Complications Trial Research Group (15 Apr 1995). "The effect of intensive diabetes therapy on the development and progression of neuropathy". Annals of Internal Medicine 122 (8): 561–568. ISSN 0003-4819. PMID 7887548. http://www.annals.org/cgi/content/abstract/122/8/561.
· ^ a b Harris MI, Flegal KM, Cowie CC, et al (1998). "Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994". Diabetes Care 21 (4): 518–24. doi:10.2337/diacare.21.4.518. PMID 9571335.
· ^ Annette M. Chang and Jeffrey B. Halter (2003). "Aging and insulin secretion". AJP - Endocrinology and Metabolism. http://ajpendo.physiology.org/cgi/content/full/284/1/E7?ck=nck. Retrieved on 2007-05-14.
· ^ "Diabetes and Aging". Diabetes Dateline. National Institute of Diabetes and Digestive and Kidney Diseases. 2002. http://diabetes.niddk.nih.gov/about/dateline/spri02/8.htm. Retrieved on 2007-05-14.
· ^ Weiss J, Sumpio B (2006). "Review of prevalence and outcome of vascular disease in patients with diabetes mellitus". Eur J Vasc Endovasc Surg 31 (2): 143–50. doi:10.1016/j.ejvs.2005.08.015. PMID 16203161.
· ^ Aristides Veves, Rayaz A. Malik (2007). Diabetic Neuropathy: Clinical Management (Clinical Diabetes), Second Edition. New York: Humana Press. pp. 188–198. ISBN 1-58-829626-1.
· ^ Gispen WH, Biessels GJ (November 2000). "Cognition and synaptic plasticity in diabetes mellitus". Trends Neurosci. 23 (11): 542–9. doi:10.1016/S0166-2236(00)01656-8. PMID 11074263.
· ^ a b c d Wild S, Roglic G, Green A, Sicree R, King H (May 2004). "Global prevalence of diabetes: estimates for the year 2000 and projections for 2030". Diabetes Care 27 (5): 1047–53. doi:10.2337/diacare.27.5.1047. PMID 15111519. http://care.diabetesjournals.org/cgi/content/full/27/5/1047.
· ^ hhttp://www.cdc.gov/Features/diabetesfactsheet/
· ^ "CDC's Diabetes Program - News and Information - Press Releases - October 26 2000". http://www.cdc.gov/Diabetes/news/docs/010126.htm. Retrieved on 2008-06-23.
· ^ Narayan K, Boyle J, Thompson T, Sorensen S, Williamson D (2003). "Lifetime risk for diabetes mellitus in the United States". JAMA 290 (14): 1884–90. doi:10.1001/jama.290.14.1884. PMID 14532317.
· ^ American Diabetes Association (2005). "Total Prevalence of Diabetes & Pre-diabetes". http://www.diabetes.org/diabetes-statistics/prevalence.jsp. Retrieved on 2006-03-17.
· ^ "Seniors and Diabetes". Elderly And Diabetes - Diabetes and Seniors. LifeMed Media. 2006. http://www.dlife.com/dLife/do/ShowContent/daily_living/seniors/. Retrieved on 2007-05-14.
· ^ Australian Institute for Health and Welfare. "Diabetes, an overview". http://www.aihw.gov.au/indigenous/health/diabetes.cfm. Retrieved on 2008-06-23.
· ^ Dobson, M. (1776). "Nature of the urine in diabetes". Medical Observations and Inquiries 5: 298–310.
· ^ Medvei (1993). History of Clinical Endocrinology. 23-34
· ^ a b Dwivedi, Girish & Dwivedi, Shridhar (2007). History of Medicine: Sushruta – the Clinician – Teacher par Excellence. National Informatics Centre (Government of India).
· ^ Nabipour, I. (2003), "Clinical Endocrinology in the Islamic Civilization in Iran", International Journal of Endocrinology and Metabolism1: 43–45 [44–5]
· ^ a b c Patlak M (2002). "New weapons to combat an ancient disease: treating diabetes". Faseb J 16 (14): 1853. doi:10.1096/fj.02-0974bkt. PMID 12468446. http://www.fasebj.org/cgi/content/full/16/14/1853e.
· ^ Von Mehring J, Minkowski O. (1890). "Diabetes mellitus nach pankreasexstirpation". Arch Exp Pathol Pharmakol 26: 371–387. doi:10.1007/BF01831214.
· ^ Banting FG, Best CH, Collip JB, Campbell WR, Fletcher AA (01 Jan 1922). "Pancreatic extracts in the treatment of diabetes mellitus". Canad Med Assoc J 12 (10): 141–146. PMID 1933711. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=1933711.
· ^ Himsworth (1936). "Diabetes mellitus: its differentiation into insulin-sensitive and insulin-insensitive types". Lancet i: 127–130. doi:10.1016/S0140-6736(01)36134-2.
· ^ Department of Health (Malta), 1897–1972:Annual Reports.
· ^ Yalow RS, Berson SA (1960). "Immunoassay of endogenous plasma insulin in man". J. Clin. Invest. 39: 1157–75. doi:10.1172/JCI104130. PMID 13846364.
· ^ The Diabetes Control And Complications Trial Research Group, (1993). "The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group". N Engl J Med 329 (14): 977–86. doi:10.1056/NEJM199309303291401. PMID 8366922.
· ^ Theodore H. Tulchinsky, Elena A. Varavikova (2008). The New Public Health, Second Edition. New York: Academic Press. p. 200. ISBN 0-12-370890-7.
· ^ Piwernetz K, Home PD, Snorgaard O, Antsiferov M, Staehr-Johansen K, Krans M. (1993). "Monitoring the targets of the St Vincent Declaration and the implementation of quality management in diabetes care: the DIABCARE initiative. The DIABCARE Monitoring Group of the St Vincent Declaration Steering Committee.". Diabet Med. 10 (4): 303–4. PMID 8508624.
· ^ Dubois, HFW and Bankauskaite, V (2005). "Type 2 diabetes programmes in Europe" (PDF). Euro Observer 7 (2): 5–6. http://www.euro.who.int/Document/Obs/EuroObserver7_3.pdf.
· ^ Stewart WF, Ricci JA, Chee E, Hirsch AG, Brandenburg NA (2007). "Lost productive time and costs due to diabetes and diabetic neuropathic pain in the US workforce". J. Occup. Environ. Med. 49 (6): 672–9. doi:10.1097/JOM.0b013e318065b83a. PMID 17563611.
· ^ Philip E. Cryer (1997). Hypoglycemia: pathophysiology, diagnosis, and treatment. Oxford [Oxfordshire]: OxfordUniversity Press. ISBN 0-19-511325-X. OCLC 36188385.
· ^ Koh TH, Eyre JA, Aynsley-Green A (1988). "Neonatal hypoglycaemia--the controversy regarding definition". Arch. Dis. Child. 63 (11): 1386–8. PMID 3202648.
· ^ Cornblath M, Schwartz R, Aynsley-Green A, Lloyd JK (1990). "Hypoglycemia in infancy: the need for a rational definition. A Ciba Foundation discussion meeting". Pediatrics 85 (5): 834–7. PMID 2330247.
· ^ Cornblath M, Hawdon JM, Williams AF, Aynsley-Green A, Ward-Platt MP, Schwartz R, Kalhan SC (2000). "Controversies regarding definition of neonatal hypoglycemia: suggested operational thresholds". Pediatrics 105 (5): 1141–5. doi:10.1542/peds.105.5.1141. PMID 10790476.
· ^ a b TustisonWA, Bowen AJ, Crampton JH (1966). "Clinical interpretation of plasma glucose values". Diabetes 15 (11): 775–7. PMID 5924610.
· ^ a b c [edited by] John Bernard Henry (1979). Clinical diagnosis and management by laboratory methods. Philadelphia: Saunders. ISBN 0-7216-4639-5. OCLC 4884633.
· ^ Clarke WL, Cox D, Gonder-Frederick LA, Carter W, Pohl SL (1987). "Evaluating clinical accuracy of systems for self-monitoring of blood glucose". Diabetes Care 10 (5): 622–8. doi:10.2337/diacare.10.5.622. PMID 3677983.
· ^ Gama R, Anderson NR, Marks V (2000). "'Glucose meter hypoglycaemia': often a non-disease". Ann. Clin. Biochem. 37 ( Pt 5): 731–2. doi:10.1258/0004563001899825. PMID 11026531.
· ^ de Pasqua A, Mattock MB, Phillips R, Keen H (1984). "Errors in blood glucose determination". Lancet 2 (8412): 1165. PMID 6150231.
· ^ Horwitz DL (1989). "Factitious and artifactual hypoglycemia". Endocrinol. Metab. Clin. North Am. 18 (1): 203–10. PMID 2645127.
· ^ Samuel Meites, editor-in-chief; contributing editors, Gregory J. Buffone... [et al.] (1989). Pediatric clinical chemistry: reference (normal) values. Washington, D.C: AACC Press. ISBN 0-915274-47-7. OCLC 18497532.
· ^ 20 White NH, Skor D, Cryer PE, Bier DM, Levandoski L, Santiago JV: Identification of type 1 diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med 308:485–491, 1983
· ^ 21 Bolli GB, De Feo P, De Cosmo S, Perriello G, Ventura MM, Massi-Benedetti M, Santeusanio F, Gerich JE, Brunetti P: A reliable and reproducible test for adequate glucose counterregulation in type 1 diabetes. Diabetes 33:732–737, 1984
· ^ edited by Allen I. Arieff, Robert C. Griggs (1992). Metabolic brain dysfunction in systemic disorders. Boston: Little, Brown. ISBN 0-316-05067-9. OCLC 24912204.
· ^ http://ajpendo.physiology.org/cgi/content/full/283/2/E207
· ^ http://jcem.endojournals.org/cgi/content/full/89/9/4450
· ^ "The Hypoglycemic states - Hypoglycemia". The Hypoglycemic states. Armenian Medical Network. 2007. http://www.health.am/db/the-hypoglycemic-states-hypoglycemia/.
· ^ a b Jack DeRuiter (2002) (PDF). Thyroid Pathology. pp. 30. http://www.auburn.edu/~deruija/endp_thyroidpathol.pdf.
· ^ Brooks W (01/06/2008). "Hypothyroidism in Dogs". The Pet Health Library. VetinaryPartner.com. http://www.veterinarypartner.com/Content.plx?P=A&A=461. Retrieved on 2008-02-28.
· ^ Simon H (2006-04-19). "Hypothyroidism". University of MarylandMedicalCenter. http://www.umm.edu/patiented/articles/what_causes_hypothyroidism_000038_2.htm. Retrieved on 2008-02-28.
· ^ Department of Pathology (June 13, 2005). "Pituitary Gland -- Diseases/Syndromes". VirginiaCommonwealthUniversity (VCU). http://www.pathology.vcu.edu/education/endocrine/endocrine/pituitary/diseases.html. Retrieved on 2008-02-28.
· ^ a b American Thyroid Association (ATA) (2003) (PDF). Hypothyroidism Booklet. pp. 6. http://www.thyroid.org/patients/brochures/Hypothyroidism%20_web_booklet.pdf#search=%22hypothyroidism%22.
· ^ Heinrich TW, Grahm G (2003). Hypothyroidism Presenting as Psychosis: Myxedema Madness Revisited. 5. pp. 260–266. PMID 15213796.
· ^ MedlinePlus Encyclopedia Hypothyroidism — primary — see list of Symptoms
· ^ "Hypothyroidism — In-Depth Report." The New York Times. Copyright 2008
· ^ "Hypothyroidism" (PDF). American Association of Clinical Endocrinologists. http://www.aace.com/pub/thyroidbrochures/pdfs/Hypothyroidism.pdf.
· ^ Yeum CH, Kim SW, Kim NH, Choi KC, Lee J (July 2002). "Increased expression of aquaporin water channels in hypothyroid rat kidney". Pharmacol. Res. 46 (1): 85–8. doi:10.1016/S1043-6618(02)00036-1. PMID 12208125.
· ^ Thyroid and Weight. The American Thyroid Association
· ^ Hofeldt FD, Dippe S, Forsham PH (1972). "Diagnosis and classification of reactive hypoglycemia based on hormonal changes in response to oral and intravenous glucose administration" (PDF). Am. J. Clin. Nutr. 25 (11): 1193–201. PMID 5086042. http://www.ajcn.org/cgi/reprint/25/11/1193.pdf.
· ^ a b Baisier W. Hertoghe J. Eeckhaut W. Thyroid insufficiency. Is TSH the only diagnostic tool? J Nutr Environ ed. 2000;10:105–113. "Thyroid insufficiency. Is TSH the only diagnostic tool?"
· ^ a b American Association of Clinical Endocrinologists (November/December 2002). "Medical Guidelines For Clinical Practice For The Evaluation And Treatment Of Hyperthyroidism And Hypothyroidism" (PDF). Endocrine Practice 8 (6): 457–469. http://www.aace.com/pub/pdf/guidelines/hypo_hyper.pdf.
· ^ a b Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ (February 1999). "Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism". N. Engl. J. Med. 340 (6): 424–9. doi:10.1056/NEJM199902113400603. PMID 9971866. http://content.nejm.org/cgi/content/full/340/6/424.
· ^ a b Baisier, W.V.; Hertoghe, J.; Eeckhaut, W. (September 2001). "Thyroid Insufficiency. Is Thyroxine the Only Valuable Drug?". Journal of Nutritional and Environmental Medicine 11 (3): 159–66. doi:10.1080/13590840120083376. — Abstract
· ^ Robertas Bunevicius, Arthur J. Prange Jr. (June 2000). "Mental improvement after replacement therapy with thyroxine plus triiodothyronine: relationship to cause of hypothyroidism". The International Journal of Neuropsychopharmacology 3 (2): 167–174. doi:10.1017/S1461145700001826. http://journals.cambridge.org/action/displayAbstract?aid=52289.
· ^ Siegmund W, Spieker K, Weike AI, et al (June 2004). "Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism". Clin. Endocrinol. (Oxf) 60 (6): 750–7. doi:10.1111/j.1365-2265.2004.02050.x. PMID 15163340.
· ^ Joffe RT, Brimacombe M, Levitt AJ, Stagnaro-Green A (2007). "Treatment of clinical hypothyroidism with thyroxine and triiodothyronine: a literature review and metaanalysis". Psychosomatics 48 (5): 379–84. doi:10.1176/appi.psy.48.5.379. PMID 17878495.
· ^ Saravanan P, Siddique H, Simmons DJ, Greenwood R, Dayan CM (April 2007). "Twenty-four hour hormone profiles of TSH, Free T3 and free T4 in hypothyroid patients on combined T3/T4 therapy". Exp. Clin. Endocrinol. Diabetes 115 (4): 261–7. doi:10.1055/s-2007-973071. PMID 17479444.
· ^ "Subclinical Thyroid Disease". Guidelines & Position Statements. The American Association of Clinical Endocrinologists. July 11, 2007. http://www.aace.com/pub/positionstatements/subclinical.php. Retrieved on 2008-06-08.
· ^ Villar H, Saconato H, Valente O, Atallah A (2007). "Thyroid hormone replacement for subclinical hypothyroidism". Cochrane database of systematic reviews (Online) (3): CD003419. doi:10.1002/14651858.CD003419.pub2. PMID 17636722.
· ^ Biondi B, Palmieri EA, Lombardi G, Fazio S (December 2002). "Effects of subclinical thyroid dysfunction on the heart". Ann. Intern. Med. 137 (11): 904–14. PMID 12458990.
· ^ Ochs N, Auer R, BauerDC, et al (June 2008). "Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality". Ann. Intern. Med.
148 (11): 832–45. PMID 18490668. http://www.annals.org/cgi/content/full/148/11/832.
· ^ Alan Gaby (2004). ""Sub-laboratory" Hypothyroidism and the Empirical use of Armour Thyroid" (PDF). Alternative Medicine Review 9 (2): 157–179. http://www.thorne.com/media/hypothyroidism9-2.pdf.
· ^ Faculty of Medicine & Dentistry (2006). "Course-Based Physical Examination - Endocrinology -- Endocrinology Objectives (Thyroid Exam)". Undergraduate Medical Education. University of Alberta. http://www.med.ualberta.ca/education/ugme/clinicaled12/clinskills_endocrinology.cfm?yr=1. Retrieved on 2007-01-28.
· ^ Geffner, DL, Hershman, JM.ß-adrenergic blockade for the treatment of hyperthyroidism. Am J Med 1992; 93:61.
· ^ Berglund J, Christensen SB, Dymling JF, Hallengren B (1991). "The incidence of recurrence and hypothyroidism following treatment with antithyroid drugs, surgery or radioiodine in all patients with thyrotoxicosis in Malmö during the period 1970-1974". J. Intern. Med. 229 (5): 435–42. PMID 1710255.
· ^ Esfahani AF, Kakhki VR, Fallahi B, et al (2005). "Comparative evaluation of two fixed doses of 185 and 370 MBq 131I, for the treatment of Graves' disease resistant to antithyroid drugs". Hellenic journal of nuclear medicine 8 (3): 158–61. PMID 16390021.
· ^ Markovic V, Eterovic D (2007). "Thyroid echogenicity predicts outcome of radioiodine therapy in patients with Graves' disease". J. Clin. Endocrinol. Metab. 92 (9): 3547–52. doi:10.1210/jc.2007-0879. PMID 17609305.
· ^ http://www.thyroid-info.com/articles/cat-hyper.htm
· ^ Susan Little (2006). "Feline Hyperthyroidism" (PDF). Winn Feline Foundation. http://www.winnfelinehealth.org/Pages/Feline_Hyperthyroidism_Web.pdf. Retrieved on 2007-01-28.
· ^ "Diabetes Blue Circle Symbol". International Diabetes Federation. 17 March 2006. http://www.diabetesbluecircle.org.
· ^ L M Tierney, S J McPhee, M A Papadakis (2002). Current medical Diagnosis & Treatment. International edition. New York: Lange Medical Books/McGraw-Hill. pp. 1203–1215. ISBN 0-07-137688-7.
· ^ a b c Rother, KI (2007). "Diabetes Treatment — Bridging the Divide". N Engl J Med 356 (15): 1499–1501. doi:10.1056/NEJMp078030. PMID 17429082. http://content.nejm.org/cgi/content/full/356/15/1499.
· ^ a b c World Health Organisation Department of Noncommunicable Disease Surveillance (1999). "Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications" (PDF). http://whqlibdoc.who.int/hq/1999/WHO_NCD_NCS_99.2.pdf.
· ^ Mailloux, Lionel (2007-02-13). "UpToDate Dialysis in diabetic nephropathy". UpToDate. http://patients.uptodate.com/topic.asp?file=dialysis/15147. Retrieved on 2007-12-07.
· ^ "Other "types" of diabetes". American Diabetes Association. August 25, 2005. http://www.diabetes.org/other-types.jsp.
· ^ "Diseases: Johns Hopkins Autoimmune Disease Research Center". http://autoimmune.pathology.jhmi.edu/diseases.cfm?systemID=3&DiseaseID=23. Retrieved on 2007-09-23.
· ^ "FDA Approves First Ever Inhaled Insulin Combination Product for Treatment of Diabetes". http://www.fda.gov/bbs/topics/news/2006/NEW01304.html. Retrieved on 2007-09-09.
· ^ "MannKind Unveils Proposed Trade Name at Dedication of Danbury Manufacturing Facility". http://www.mannkindcorp.com/pressreleasetext.aspx?releaseID=1198182. Retrieved on 2008-10-23.
· ^ Baillie, K (2008-07-05). "ClinicLog article on current diabetes trials.". ClinicLog.com. http://www.cliniclog.com/type_1_diabetes_trials.php. Retrieved on 2008-07-23.
· ^ Eberhart, MS; Ogden C, Engelgau M, Cadwell B, Hedley AA, Saydah SH (19 November 2004). "Prevalence of Overweight and Obesity Among Adults with Diagnosed Diabetes --- United States, 1988--1994 and 1999--2002". Morbidity and Mortality Weekly Report (Centers for Disease Control and Prevention) 53 (45): 1066–1068. http://www.cdc.gov/mmwR/preview/mmwrhtml/mm5345a2.htm. Retrieved on 2007-03-11.
· ^ Arlan Rosenbloom, Janet H Silverstein (2003). Type 2 Diabetes in Children and Adolescents: A Clinician's Guide to Diagnosis, Epidemiology, Pathogenesis, Prevention, and Treatment. American Diabetes Association,U.S.. pp. 1. ISBN 978-1580401555.
· ^ Lang, Iain A.; Tamara S. Galloway, Alan Scarlett, William E. Henley, Michael Depledge, Robert B. Wallace, and David Melzer (2008). "Association of Urinary Bisphenol A Concentration with Medical Disorders and Laboratory Abnormalities in Adults". Journal of the American Medical Association 300 (1): 1303–1310. doi:10.1001/jama.300.11.1303.
· ^ "Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group". Lancet 352 (9131): 854–65. 1998. doi:10.1016/S0140-6736(98)07037-8. PMID 9742977.
· ^ Lawrence JM, Contreras R, Chen W, Sacks DA (May 2008). "Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999-2005". Diabetes Care 31 (5): 899–904. doi:10.2337/dc07-2345. PMID 18223030.
· ^ Lyssenko, V. (2008). "Clinical risk factors, DNA variants, and the development of type 2 diabetes". N Engl J Med 359 (21): 2220–2232. doi:10.1056/NEJMoa0801869. http://content.nejm.org/cgi/content/short/359/21/2220?query=TOC.
· ^ Walley AJ, Blakemore AI, Froguel P (2006). "Genetics of obesity and the prediction of risk for health". Hum. Mol. Genet. 15 Spec No 2: R124–30. doi:10.1093/hmg/ddl215. PMID 16987875.
· ^ "Monogenic Forms of Diabetes: Neonatal Diabetes Mellitus and Maturity-onset Diabetes of the Young". National Diabetes Information Clearinghouse (NDIC) (National Institute of Diabetes and Digestive and Kidney Diseases, NIH). http://www.diabetes.niddk.nih.gov/dm/pubs/mody/. Retrieved on 2008-08-04.
· ^ Barrett TG (2001). "Mitochondrial diabetes, DIDMOAD and other inherited diabetes syndromes". Best Pract. Res. Clin. Endocrinol. Metab. 15 (3): 325–43. doi:10.1053/beem.2001.0149. PMID 11554774.
· ^ Santaguida PL, Balion C, Hunt D, Morrison K, Gerstein H, Raina P, Booker L, Yazdi H. "Diagnosis, Prognosis, and Treatment of Impaired Glucose Tolerance and Impaired Fasting Glucose". Summary of Evidence Report/Technology Assessment, No. 128. Agency for Healthcare Research and Quality. http://www.ahrq.gov/clinic/epcsums/impglusum.htm. Retrieved on 2008-07-20.
· ^ Sniderman, AD; Bhopal R, Prabhakaran D, Sarrafzadegan N, Tchernof A (2007). "Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis". International journal of epidemiology 36 (1): 220–225. doi:10.1093/ije/dyl245. PMID 17510078.
· ^ Genuth S (Jan-Feb 2006). "Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes". Endocr Pract 12 (Suppl 1): 34–41. ISSN 1530-891X. PMID 16627378.
· ^ Lee CM, Huxley RR, Lam TH, Martiniuk AL, Ueshema H, Pan WH, Welborn T, Woodward M; Asia Pacific Cohort Studies Collaboration (2007). "Prevalence of diabetes mellitus and population attributable fractions for coronary heart disease and stroke mortality in the WHO South-East Asia and Western Pacific regions". Asia Pac J Clin Nutr 16 (1): 187–92. PMID 17215197.
· ^ Seidell JC (2000). "Obesity, insulin resistance and diabetes--a worldwide epidemic". Br. J. Nutr. 83 Suppl 1: S5–8. PMID 10889785.
· ^ Daneman D (2006). "Type 1 diabetes". Lancet 367 (9513): 847–58. doi:10.1016/S0140-6736(06)68341-4. PMID 16530579.
· ^ Borch-Johnsen K, Joner G, Mandrup-Poulsen T, Christy M, Zachau-Christiansen B, Kastrup K, Nerup J (1984). "Relation between breast-feeding and incidence rates of insulin-dependent diabetes mellitus. A hypothesis". Lancet 2 (8411): 1083–6. doi:10.1016/S0140-6736(84)91517-4. PMID 6150150.
· ^ Naim Shehadeh, Raanan Shamir, Moshe Berant, Amos Etzioni (2001). "Insulin in human milk and the prevention of type 1 diabetes". Pediatric Diabetes 2 (4): 175–177. doi:10.1034/j.1399-5448.2001.20406.x. http://www.blackwell-synergy.com/doi/abs/10.1034/j.1399-5448.2001.20406.x?journalCode=pdi.
· ^ Virtanen S, Knip M (2003). "Nutritional risk predictors of beta cell autoimmunity and type 1 diabetes at a young age". Am J Clin Nutr 78 (6): 1053–67. PMID 14668264.
· ^ Hyppönen E, Läärä E, Reunanen A, Järvelin MR, Virtanen SM (2001). "Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study". Lancet 358: 1500. doi:10.1016/S0140-6736(01)06580-1. PMID 11705562.
· ^ Elliott RB, Pilcher CC, Fergusson DM, Stewart AW (Sep-Oct 1996). "A population based strategy to prevent insulin-dependent diabetes using nicotinamide". J. Pediatr. Endocrinol. Metab. 9 (5): 501–9. PMID 8961125.
· ^ Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson J, Hemiö K, Hämäläinen H, Härkönen P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Paturi M, Sundvall J, Valle T, Uusitupa M, Tuomilehto J (2006). "Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study". Lancet 368 (9548): 1673–9. doi:10.1016/S0140-6736(06)69701-8. PMID 17098085.
· ^ a b Knowler W, Barrett-Connor E, Fowler S, Hamman R, Lachin J, Walker E, Nathan D (2002). "Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin". N Engl J Med 346 (6): 393–403. doi:10.1056/NEJMoa012512. PMID 11832527.
· ^ Bantle JP, Wylie-Rosett J, Albright AL, et al (2006). "Nutrition recommendations and interventions for diabetes--2006: a position statement of the American Diabetes Association". Diabetes Care 29 (9): 2140–57. doi:10.2337/dc06-9914. PMID 16936169. http://care.diabetesjournals.org/cgi/content/full/29/9/2140.
· ^ Gerstein H, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, Hanefeld M, Hoogwerf B, Laakso M, Mohan V, Shaw J, Zinman B, Holman R (2006). "Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial". Lancet 368 (9541): 1096–105. doi:10.1016/S0140-6736(06)69420-8. PMID 16997664.
· ^ Kjeldsen SE, Julius S, Mancia G, McInnes GT, Hua T, Weber MA, Coca A, Ekman S, Girerd X, Jamerson K, Larochelle P, Macdonald TM, Schmieder RE, Schork MA, Stolt P, Viskoper R, Widimsky J, Zanchetti A; for the VALUE Trial Investigators (2006). "Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial". J Hypertens 24 (7): 1405–1412. doi:10.1097/01.hjh.0000234122.55895.5b. PMID 16794491.
· ^ Wasko MC, Hubert HB, Lingala VB, et al (2007). "Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis". JAMA 298 (2): 187–93. doi:10.1001/jama.298.2.187. PMID 17622600.
· ^ Stuebe AM, Rich-Edwards JW, Willett WC, Manson JE, Michels KB (2005). "Duration of lactation and incidence of type 2 diabetes". JAMA 294 (20): 2601–10. doi:10.1001/jama.294.20.2601. PMID 16304074.
· ^ Adler, A.I.; Stratton, I. M.; Neil, H.A.; et al (2000). "Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study". BMJ 321 (7258): 412–419. doi:10.1136/bmj.321.7258.412. PMID 10938049. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=27454&rendertype=abstract.
· ^ a b c Vinik AI, Fishwick DT, Pittenger G (2004). "Advances in diabetes for the millennium: toward a cure for diabetes". MedGenMed : Medscape general medicine 6 (3 Suppl): 12. PMID 15647717.
· ^ Stratta RJ, Alloway RR. (1998). "Pancreas transplantation for diabetes mellitus: a guide to recipient selection and optimum immunosuppression". BioDrugs. 10 (5): 347–357. doi:10.2165/00063030-199810050-00002. PMID 18020607.
· ^ Shapiro AM, Ricordi C, Hering BJ, et al (2006). "International trial of the Edmonton protocol for islet transplantation". N. Engl. J. Med. 355 (13): 1318–30. doi:10.1056/NEJMoa061267. PMID 17005949.
· ^ Voltarelli, JC; Couri CE, Stracieri AB, Oliveira MC, Moraes DA, Pieroni F, Coutinho M, Malmegrim KC, Foss-Freitas MC, Simoes BP, Foss MC, Squiers E, Burt RK. (2007). "Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus". JAMA 297 (14): 1568–76. doi:10.1001/jama.297.14.1568. PMID 17426276. http://jama.ama-assn.org/cgi/content/full/297/14/1568.
· ^ Rubino, F; Gagner M (2002). "Potential of surgery for curing type 2 diabetes mellitus". Ann. Surg. 236 (5): 554–9. doi:10.1097/00000658-200211000-00003. PMID 12409659.
· ^ Adams, TD; Gress RE, SmithSC, et al (2007). "Long-term mortality after gastric bypass surgery". N. Engl. J. Med. 357 (8): 753–61. doi:10.1056/NEJMoa066603. PMID 17715409.
· ^ Cohen, RV; SchiavonCA, Pinheiro JS, Correa JL, Rubino F (2007). "Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases". Surg Obes Relat Dis. 3 (2): 195–7. doi:10.1016/j.soard.2007.01.009. PMID 17386401.
· ^ Vasonconcelos, Alberto (2007-09-01). "Could type 2 diabetes be reversed using surgery?". New Scientist (2619): 11–13. http://www.newscientist.com/channel/health/mg19526193.100-could-type-2-diabetes-be-reversed-using-surgery.html. Retrieved on 2007-09-26.
· ^ Nathan, D.M.; Cleary P.A., Backlund J.Y., et al (2005). "Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes". N. Engl. J. Med. 353 (25): 2643–53. doi:10.1056/NEJMoa052187. PMID 16371630.
· ^ The Diabetes Control and Complications Trial Research Group (15 Apr 1995). "The effect of intensive diabetes therapy on the development and progression of neuropathy". Annals of Internal Medicine 122 (8): 561–568. ISSN 0003-4819. PMID 7887548. http://www.annals.org/cgi/content/abstract/122/8/561.
· ^ a b Harris MI, Flegal KM, Cowie CC, et al (1998). "Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994". Diabetes Care 21 (4): 518–24. doi:10.2337/diacare.21.4.518. PMID 9571335.
· ^ Annette M. Chang and Jeffrey B. Halter (2003). "Aging and insulin secretion". AJP - Endocrinology and Metabolism. http://ajpendo.physiology.org/cgi/content/full/284/1/E7?ck=nck. Retrieved on 2007-05-14.
· ^ "Diabetes and Aging". Diabetes Dateline. National Institute of Diabetes and Digestive and Kidney Diseases. 2002. http://diabetes.niddk.nih.gov/about/dateline/spri02/8.htm. Retrieved on 2007-05-14.
· ^ Weiss J, Sumpio B (2006). "Review of prevalence and outcome of vascular disease in patients with diabetes mellitus". Eur J Vasc Endovasc Surg 31 (2): 143–50. doi:10.1016/j.ejvs.2005.08.015. PMID 16203161.
· ^ Aristides Veves, Rayaz A. Malik (2007). Diabetic Neuropathy: Clinical Management (Clinical Diabetes), Second Edition. New York: Humana Press. pp. 188–198. ISBN 1-58-829626-1.
· ^ Gispen WH, Biessels GJ (November 2000). "Cognition and synaptic plasticity in diabetes mellitus". Trends Neurosci. 23 (11): 542–9. doi:10.1016/S0166-2236(00)01656-8. PMID 11074263.
· ^ a b c d Wild S, Roglic G, Green A, Sicree R, King H (May 2004). "Global prevalence of diabetes: estimates for the year 2000 and projections for 2030". Diabetes Care 27 (5): 1047–53. doi:10.2337/diacare.27.5.1047. PMID 15111519. http://care.diabetesjournals.org/cgi/content/full/27/5/1047.
· ^ hhttp://www.cdc.gov/Features/diabetesfactsheet/
· ^ "CDC's Diabetes Program - News and Information - Press Releases - October 26 2000". http://www.cdc.gov/Diabetes/news/docs/010126.htm. Retrieved on 2008-06-23.
· ^ Narayan K, Boyle J, Thompson T, Sorensen S, Williamson D (2003). "Lifetime risk for diabetes mellitus in the United States". JAMA 290 (14): 1884–90. doi:10.1001/jama.290.14.1884. PMID 14532317.
· ^ American Diabetes Association (2005). "Total Prevalence of Diabetes & Pre-diabetes". http://www.diabetes.org/diabetes-statistics/prevalence.jsp. Retrieved on 2006-03-17.
· ^ "Seniors and Diabetes". Elderly And Diabetes - Diabetes and Seniors. LifeMed Media. 2006. http://www.dlife.com/dLife/do/ShowContent/daily_living/seniors/. Retrieved on 2007-05-14.
· ^ Australian Institute for Health and Welfare. "Diabetes, an overview". http://www.aihw.gov.au/indigenous/health/diabetes.cfm. Retrieved on 2008-06-23.
· ^ Dobson, M. (1776). "Nature of the urine in diabetes". Medical Observations and Inquiries 5: 298–310.
· ^ Medvei (1993). History of Clinical Endocrinology. 23-34
· ^ a b Dwivedi, Girish & Dwivedi, Shridhar (2007). History of Medicine: Sushruta – the Clinician – Teacher par Excellence. National Informatics Centre (Government of India).
· ^ Nabipour, I. (2003), "Clinical Endocrinology in the Islamic Civilization in Iran", International Journal of Endocrinology and Metabolism1: 43–45 [44–5]
· ^ a b c Patlak M (2002). "New weapons to combat an ancient disease: treating diabetes". Faseb J 16 (14): 1853. doi:10.1096/fj.02-0974bkt. PMID 12468446. http://www.fasebj.org/cgi/content/full/16/14/1853e.
· ^ Von Mehring J, Minkowski O. (1890). "Diabetes mellitus nach pankreasexstirpation". Arch Exp Pathol Pharmakol 26: 371–387. doi:10.1007/BF01831214.
· ^ Banting FG, Best CH, Collip JB, Campbell WR, Fletcher AA (01 Jan 1922). "Pancreatic extracts in the treatment of diabetes mellitus". Canad Med Assoc J 12 (10): 141–146. PMID 1933711. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=1933711.
· ^ Himsworth (1936). "Diabetes mellitus: its differentiation into insulin-sensitive and insulin-insensitive types". Lancet i: 127–130. doi:10.1016/S0140-6736(01)36134-2.
· ^ Department of Health (Malta), 1897–1972:Annual Reports.
· ^ Yalow RS, Berson SA (1960). "Immunoassay of endogenous plasma insulin in man". J. Clin. Invest. 39: 1157–75. doi:10.1172/JCI104130. PMID 13846364.
· ^ The Diabetes Control And Complications Trial Research Group, (1993). "The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group". N Engl J Med 329 (14): 977–86. doi:10.1056/NEJM199309303291401. PMID 8366922.
· ^ Theodore H. Tulchinsky, Elena A. Varavikova (2008). The New Public Health, Second Edition. New York: Academic Press. p. 200. ISBN 0-12-370890-7.
· ^ Piwernetz K, Home PD, Snorgaard O, Antsiferov M, Staehr-Johansen K, Krans M. (1993). "Monitoring the targets of the St Vincent Declaration and the implementation of quality management in diabetes care: the DIABCARE initiative. The DIABCARE Monitoring Group of the St Vincent Declaration Steering Committee.". Diabet Med. 10 (4): 303–4. PMID 8508624.
· ^ Dubois, HFW and Bankauskaite, V (2005). "Type 2 diabetes programmes in Europe" (PDF). Euro Observer 7 (2): 5–6. http://www.euro.who.int/Document/Obs/EuroObserver7_3.pdf.
· ^ Stewart WF, Ricci JA, Chee E, Hirsch AG, Brandenburg NA (2007). "Lost productive time and costs due to diabetes and diabetic neuropathic pain in the US workforce". J. Occup. Environ. Med. 49 (6): 672–9. doi:10.1097/JOM.0b013e318065b83a. PMID 17563611.
· ^ Boulpaep, Emile L.; Boron, Walter F. (2003). Medical physiology: a cellular and molecular approach. Philadelphia: Saunders. pp. 1065. ISBN 0-7216-3256-4.
· ^ EBSCO database verified by URAC; accessed from Mount Sinai Hospital, New York
· ^ Online 'Mendelian Inheritance in Man' (OMIM) MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A -171400
· ^ Diouf B, Ka EH, Calender A, Giraud S, Diop TM (2000). "Association of medullary sponge kidney disease and multiple endocrine neoplasia type IIA due to RET gene mutation: is there a causal relationship?". Nephrol. Dial. Transplant. 15 (12): 2062–3. doi:10.1093/ndt/15.12.2062. PMID 11096158.
· ^ JaroszewskiDE, Tessier DJ, Schlinkert RT, et al (2003). "Laparoscopic adrenalectomy for pheochromocytoma". Mayo Clin. Proc. 78 (12): 1501–4. doi:10.4065/78.12.1501. PMID 14661679.
· ^ aldosteronism at Dorland's Medical Dictionary
· ^ LaffertyAR, Torpy DJ, Stowasser M, et al (November 2000). "A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22)". J. Med. Genet. 37 (11): 831–5. PMID 11073536. PMC: 1734468. http://jmg.bmj.com/cgi/pmidlookup?view=long&pmid=11073536.
· ^ Kumar, Abbas, Fausto. Robbins and Cotran Pathologic Basis of Disease, 7th ed. Elsevier-Saunders; New York, 2005.
· ^ Cushing HW. (1932). "The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism).". Bull Johns Hopkins Hosp 50: 137–95.
· ^ Yudofsky, Stuart C.; Robert E. Hales (2007). The American Psychiatric Publishing Textbook of Neuropsychiatry and Behavioral Neurosciences (5th ed.). American Psychiatric Pub, Inc.. ISBN 1585622397.
· ^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0-7216-2921-0.
· ^ Raff H, Findling JW (2003). "A physiologic approach to diagnosis of the Cushing syndrome". Ann. Intern. Med. 138 (12): 980–91. PMID 12809455. http://www.annals.org/cgi/pmidlookup?view=long&pmid=12809455.
· ^ Nelson DH, Meakin JW, Thorn GW (1960). "ACTH-producing pituitary tumors following adrenalectomy for Cushing syndrome". Ann. Intern. Med. 52: 560–9. PMID 14426442.
· ^ Ezzat S, Asa SL, Couldwell WT, et al (2004). "The prevalence of pituitary adenomas: a systematic review". Cancer 101 (3): 613–9. doi:10.1002/cncr.20412. PMID 15274075.
· ^ a b c Eileen K. Corrigan (2007). "Adrenal Insufficiency (Secondary Addison's or Addison's Disease)". NIH Publication No. 90-3054. http://www.pituitary.org/disorders/addisons_disease.aspx.
· ^ MeSH Adrenal+Insufficiency
· ^ Ten S, New M, Maclaren N (2001). "Clinical review 130: Addison's disease 2001". J. Clin. Endocrinol. Metab. 86 (7): 2909–22. doi:10.1210/jc.86.7.2909. PMID 12899587. http://jcem.endojournals.org/cgi/content/full/86/7/2909.
· ^ a b c d e f g Ashley B. Grossman, MD (2007). "Addison's Disease". Adrenal Gland Disorders. http://www.merck.com/mmhe/sec13/ch164/ch164b.html.
· ^ Brender E, Lynm C, Glass RM (2005). "JAMA patient page. Adrenal insufficiency". JAMA 294 (19): 2528. doi:10.1001/jama.294.19.2528. PMID 16287965. http://jama.ama-assn.org/cgi/content/full/294/19/2528.
· ^ "Dorlands Medical Dictionary:adrenal insufficiency". http://www.mercksource.com/pp/us/cns/cns_hl_dorlands_split.jsp?pg=/ppdocs/us/common/dorlands/dorland/four/000053970.htm.
· ^ "Secondary Adrenal Insufficiency: Adrenal Disorders: Merck Manual Professional". http://www.merck.com/mmpe/sec12/ch153/ch153c.html.
· ^ "hypopituitary". 2006. http://www.webmd.com/a-to-z-guides/hypopituitary.
· ^ Thomas A Wilson, MD (2007). "Adrenal Insufficiency". Adrenal Gland Disorders. http://www.emedicine.com/PED/topic47.htm.
· ^ Thomas A Wilson, MD (1999). Adrenoleukodystrophy. http://healthlink.mcw.edu/article/921176192.html.
^ http://www.merck.com/mmhe/sec13/ch162/ch162e.html Acromegaly and Gigantism
^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0721629210.
^ Baseball's Steroid Era
^ "Andre the Giant: Bio". WWE.com. http://www.wwe.com/superstars/halloffame/andrethegiant/bio/. Retrieved on 2007-10-16.
^ "André the Giant official website.". http://www.andrethegiant.com/. Retrieved on 2007-07-08.
^ [1]
^ http://www.barrybrown.info/unsungheroes/rondohatton.html
^ BBC News report on Punch and Acromegaly
^ Login IS, Login J (July 2008). "Governor Pio Pico, the monster of California...no more: lessons in neuroendocrinology". Pituitary. doi:10.1007/s11102-008-0127-1. PMID 18597174. Open Access; http://www.springerlink.com/content/u7645787h2435373/fulltext.pdf
^ Nawar RN, AbdelMannan D, Selman WR, Arafah BM (2008). "Pituitary tumor apoplexy: a review". J Intensive Care Med 23 (2): 75–90. doi:10.1177/0885066607312992. PMID 18372348.
Endocrine and Metabolic Diseases Information Service
^ Gigantism at Dorland's Medical Dictionary
^ pituitary gigantism at Dorland's Medical Dictionary
^ Sotos syndrome at Dorland's Medical Dictionary
· ^ a b c d e f g h i j k l m n o p q r s t u v w x y z aa ab ac Schneider HJ, Aimaretti G, Kreitschmann-Andermahr I, Stalla GK, Ghigo E (April 2007). "Hypopituitarism". Lancet 369 (9571): 1461–70. doi:10.1016/S0140-6736(07)60673-4. PMID 17467517.
· ^ Hypopituitarism at Dorland's Medical Dictionary
· ^ Panhypopituitarism at Dorland's Medical Dictionary
· ^ a b Simmonds (1914). "Über hypophysisschwund mit todlichem ausgang". Dtsch Med Wschr 40: 322.
· ^ a b c d e f g h i j k l m n o p q r s t u v w van Aken MO, Lamberts SW (2005). "Diagnosis and treatment of hypopituitarism: an update". Pituitary 8 (3-4): 183–91. doi:10.1007/s11102-006-6039-z. PMID 16508719.
· ^ a b c d Regal M, Páramo C, Sierra SM, Garcia-Mayor RV (December 2001). "Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain". Clin. Endocrinol. (Oxf) 55 (6): 735–40. doi:10.1046/j.1365-2265.2001.01406.x. PMID 11895214.
· ^ a b c d e f g h i j k l m n o p q Prabhakar VK, Shalet SM (April 2006). "Aetiology, diagnosis, and management of hypopituitarism in adult life". Postgrad Med J 82 (966): 259–66. doi:10.1136/pgmj.2005.039768. PMID 16597813. http://pmj.bmj.com/cgi/content/full/82/966/259.
· ^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0721629210.
· ^ Arlt W, Allolio B (May 2003). "Adrenal insufficiency". Lancet 361 (9372): 1881–93. doi:10.1016/S0140-6736(03)13492-7. PMID 12788587.
· ^ Maghnie M (2003). "Diabetes insipidus". Horm. Res. 59 Suppl 1: 42–54. doi:10.1159/000067844. PMID 12566720.
· ^ a b c d e f g Melmed S, Jameson JL (2005). "Disorders of the anterior pituitary and hypothalamus". in Kasper DL, Braunwald E, Fauci AS, et al. Harrison's Principles of Internal Medicine (16th ed.). New York, NY: McGraw-Hill. pp. 2076–97. ISBN 0-071-39140-1.
· ^ Kaushal K, Shalet SM (2007). "Defining growth hormone status in adults with hypopituitarism". Horm. Res. 68 (4): 185–94. doi:10.1159/000101286. PMID 17389809.
· ^ a b DorinRI, Qualls CR, Crapo LM (2003). "Diagnosis of adrenal insufficiency". Ann. Intern. Med. 139 (3): 194–204. PMID 12899587. http://www.annals.org/cgi/content/full/139/3/194.
· ^ a b c d Cohen LE, Radovick S (August 2002). "Molecular basis of combined pituitary hormone deficiencies". Endocr. Rev. 23 (4): 431–42. doi:10.1210/er.2001-0030. PMID 12202459. http://edrv.endojournals.org/cgi/content/full/23/4/431.
· ^ a b c Kelberman D, DattaniMT (August 2007). "Hypothalamic and pituitary development: novel insights into the aetiology". Eur. J. Endocrinol. 157 Suppl 1: S3–14. doi:10.1530/EJE-07-0156. PMID 17785694. http://www.eje-online.org/cgi/content/full/157/suppl_1/S3.
· ^ Guillemin R (January 2005). "Hypothalamic hormones a.k.a. hypothalamic releasing factors". J. Endocrinol. 184 (1): 11–28. doi:10.1677/joe.1.05883. PMID 15642779. http://joe.endocrinology-journals.org/cgi/content/full/184/1/11.
· ^ a b c Arafah BM, Nasrallah MP (December 2001). "Pituitary tumors: pathophysiology, clinical manifestations and management" (PDF). Endocr. Relat. Cancer 8 (4): 287–305. doi:10.1677/erc.0.0080287. PMID 11733226. http://erc.endocrinology-journals.org/cgi/reprint/8/4/287.
· ^ Schlechte JA (November 2003). "Prolactinoma". N. Engl. J. Med. 349 (21): 2035–41. doi:10.1056/NEJMcp025334. PMID 14627789.
· ^ Pietrangelo A (June 2004). "Hereditary hemochromatosis--a new look at an old disease". N. Engl. J. Med. 350 (23): 2383–97. doi:10.1056/NEJMra031573. PMID 15175440.
· ^ Tomlinson JW, Holden N, Hills RK, et al (February 2001). "Association between premature mortality and hypopituitarism". Lancet 357 (9254): 425–31. doi:10.1016/S0140-6736(00)04006-X. PMID 11273062.
· ^ Schneider HJ, Kreitschmann-Andermahr I, Ghigo E, Stalla GK, Agha A (September 2007). "Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review". Journal of the American Medical Association 298 (12): 1429–38. doi:10.1001/jama.298.12.1429. PMID 17895459. http://jama.ama-assn.org/cgi/content/full/298/12/1429.
· ^ Behan LA, Phillips J, Thompson CJ, Agha A (July 2008). "Neuroendocrine disorders after traumatic brain injury". J. Neurol. Neurosurg. Psychiatr. 79 (7): 753–9. doi:10.1136/jnnp.2007.132837. PMID 18559460.
· ^ a b c Sellwood RA, Welbourn RB, Friesen SR (1990). The History of Endocrine Surgery:. New York: Praeger Publishers. ISBN 0-275-92586-2.
· ^ synd/2008 at Who Named It?
· ^ Simmonds disease at Dorland's Medical Dictionary
· ^ Yalow RS, Berson SA (July 1960). "Immunoassay of endogenous plasma insulin in man". J. Clin. Invest. 39: 1157–75. doi:10.1172/JCI104130. PMID 13846364.
· ^ Harsoulis P, Marshall JC, Kuku SF, Burke CW, London DR, Fraser TR (November 1973). "Combined test for assessment of anterior pituitary function". Br Med J 4 (5888): 326–9. doi:10.1136/bmj.4.5888.326. PMID 4202260.
http://en.wikipedia.org/wiki/Pituitary_tumour
· ^ "Pituitary Disorders". http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/pituitary/pituitary.htm#apoplexy.
· ^ Biousse V, NewmanNJ, OyesikuNM (October 2001). "Precipitating factors in pituitary apoplexy". J. Neurol. Neurosurg. Psychiatr. 71 (4): 542–5. doi:10.1136/jnnp.71.4.542. PMID 11561045. http://jnnp.bmj.com/cgi/pmidlookup?view=long&pmid=11561045.
· ^ "Growth Hormone Deficiency". UK Child Growth Foundation. http://www.childgrowthfoundation.org/ghd.htm. Retrieved on 2009-01-16.
· ^ a b "Growth failure (in children) - human growth hormone (HGH)" (pdf). National Institute for Clinical Excellence. 2008-09-25. http://www.nice.org.uk/nicemedia/pdf/HGHFinalProtocol.pdf. Retrieved on 2009-01-16.
· ^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0721629210.
· ^ a b c d e "The Use of Growth Hormone Replacement in Adult Patients with Severe Growth Hormone Deficiency" (pdf). The Society for Endocrinology. 2000-10-01. http://www.endocrinology.org/policy/docs/_gh.pdf. Retrieved on 2009-01-18.
· ^ a b c d "Human growth hormone (somatropin) in adults with growth hormone deficiency". National Institute for Clinical Excellence. 2006-07-01. http://www.nice.org.uk/nicemedia/pdf/TA64_HGHadults_fullguidance.pdf. Retrieved on 2009-01-16.
· ^ RappoldGA, Fukami M, Niesler B, et al (March 2002). "Deletions of the homeobox gene SHOX (short stature homeobox) are an important cause of growth failure in children with short stature". J. Clin. Endocrinol. Metab. 87 (3): 1402–6. doi:10.1210/jc.87.3.1402. PMID 11889216. http://jcem.endojournals.org/cgi/pmidlookup?view=long&pmid=11889216.
· ^ Saborio P, Hahn S, Hisano S, Latta K, Scheinman JI, Chan JC (October 1998). "Chronic renal failure: an overview from a pediatric perspective". Nephron 80 (2): 134–48. doi:10.1159/000045157. PMID 9736810. http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=nef80134.
· ^ a b Molitch ME, Clemmons DR, Malozowski S, et al (May 2006). "Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline". J. Clin. Endocrinol. Metab. 91 (5): 1621–34. doi:10.1210/jc.2005-2227. PMID 16636129.
· ^ a b Aimaretti G, Corneli G, Razzore P, et al (May 1998). "Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults". J. Clin. Endocrinol. Metab. 83 (5): 1615–8. doi:10.1210/jc.83.5.1615. PMID 9589665. http://jcem.endojournals.org/cgi/pmidlookup?view=long&pmid=9589665. Retrieved on 2008-07-23.
· ^ "Guidance on the use of human growth hormone (somatropin) in children with growth failure" (pdf). National Institute for Clinical Excellence. 2002-05-01. http://www.nice.org.uk/nicemedia/pdf/HGHinChild-42-ALS.pdf. Retrieved on 2009-01-16.
· ^ "Consensus Guidelines for Adult Growth Hormone Deficiency 2007". http://gghjournal.com/volume24/1/ab07.cfm.
· ^ MedlinePlus Medical Encyclopedia: Osteomalacia
· ^ Eisman JA (1988). "Osteomalacia". Baillières Clin Endocrinol Metab 2 (1): 125–5.
· ^ MedlinePlus Medical Encyclopedia: Osteomalacia
· ^ Gartner LM, Greer FR (April 2003). "Prevention of rickets and vitamin D deficiency: new guidelines for vitamin D intake". Pediatrics 111 (4 Pt 1): 908–10. doi:10.1542/peds.111.4.908. PMID 12671133. http://aappolicy.aappublications.org/cgi/content/full/pediatrics;111/4/908.
^ a b c WHO (1994). "Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group". World Health Organization technical report series 843: 1–129. PMID 7941614.
^ Kim DH, VaccaroAR (2006). "Osteoporotic compression fractures of the spine; current options and considerations for treatment". The spine journal : official journal of the North American Spine Society 6 (5): 479–87. doi:10.1016/j.spinee.2006.04.013. PMID 16934715.
^ Ganz DA, Bao Y, Shekelle PG, Rubenstein LZ (2007). "Will my patient fall?". JAMA 297 (1): 77–86. doi:10.1001/jama.297.1.77. PMID 17200478.
^ Melton LJ (2003). "Epidemiology worldwide". Endocrinol. Metab. Clin. North Am. 32 (1): 1–13, v. PMID 12699289.
^ a b c d e f Raisz L (2005). "Pathogenesis of osteoporosis: concepts, conflicts, and prospects.". J Clin Invest 115 (12): 3318–25. doi:10.1172/JCI27071. PMID 16322775. http://www.jci.org/cgi/content/full/115/12/3318.
^ Ojo F, Al Snih S, Ray LA, Raji MA, MarkidesKS (2007). "History of fractures as predictor of subsequent hip and nonhip fractures among older Mexican Americans". Journal of the National Medical Association 99 (4): 412–8. PMID 17444431.
^ a b Poole KE, Compston JE (December 2006). "Osteoporosis and its management". BMJ 333 (7581): 1251–6. doi:10.1136/bmj.39050.597350.47. PMID 17170416.
^ Berg KM, Kunins HV, Jackson JL et al (2008). "Association between alcohol consumption and both osteoporotic fracture and bone density". Am J Med 121 (5): 406–18. doi:10.1016/j.amjmed.2007.12.012.
^ a b Nieves JW (2005). "Osteoporosis: the role of micronutrients.". Am J Clin Nutr 81 (5): 1232S–1239S. PMID 15883457. http://www.ajcn.org/cgi/content/full/81/5/1232S.
^ a b c d e f g h i j k l m n WHO Scientific Group on the Prevention and Management of Osteoporosis (2000 : Geneva, Switzerland) (2003). "Prevention and management of osteoporosis : report of a WHO scientific group" (pdf). http://whqlibdoc.who.int/trs/WHO_TRS_921.pdf. Retrieved on 2007-05-31.
^ Wong PK, Christie JJ, Wark JD (2007). "The effects of smoking on bone health". Clin. Sci. 113 (5): 233–41. doi:10.1042/CS20060173. PMID 17663660. http://www.clinsci.org/cs/113/0233/cs1130233.htm.
^ Shapses SA, Riedt CS (2006). "Bone, body weight, and weight reduction: what are the concerns?". J. Nutr. 136 (6): 1453–6. PMID 16702302. http://jn.nutrition.org/cgi/content/full/136/6/1453.
^ Staessen J, Roels H, Emelianov D, Kuznetsova T, Thijs L, Vangronsveld J, Fagard R (Apr 3 1999). "Environmental exposure to cadmium, forearm bone density, and risk of fractures: prospective population study. Public Health and Environmental Exposure to Cadmium (PheeCad) Study Group.". Lancet 353 (9159): 1140–4. doi:10.1016/S0140-6736(98)09356-8. PMID 10209978.
^ Tucker KL, Morita K, Qiao N, Hannan MT, Cupples LA, Kiel DP (2006). "Colas, but not other carbonated beverages, are associated with low bone mineral density in older women: The Framingham Osteoporosis Study". Am. J. Clin. Nutr. 84 (4): 936–42. PMID 17023723.
^ "Soft drinks in schools". Pediatrics 113 (1 Pt 1): 152–4. 2004. PMID 14702469.
^ Waugh EJ, Lam M-A, Hawker GA, et al. (2009). Risk factors for low bone mass in healthy 40–60 year old women: A systematic review of the literature. 20. p. 1–21. doi:10.1007/s00198-008-0643-x.
^ a b c d e Simonelli, C et al (July 2006). "ICSI Health Care Guideline: Diagnosis and Treatment of Osteoporosis, 5th edition" (PDF). Institute for Clinical Systems Improvement. http://www.icsi.org/osteoporosis/diagnosis_and_treatment_of_osteoporosis__3.html. Retrieved on 2008-04-08.
^ a b c d e f g h i j k l Kohlmeier, Lynn Kohlmeier (1998). "Osteoporosis - Risk Factors, Screening, and Treatment". Medscape Portals. http://www.medscape.com/viewarticle/427342. Retrieved on 2008-05-11.
^ a b c d Ebeling PR (2008). "Clinical practice. Osteoporosis in men". N Engl J Med 358 (14): 1474–82. doi:10.1056/NEJMcp0707217. PMID 18385499.
^ Bone and Tooth Society of Great Britain, National Osteoporosis Society, RoyalCollege of Physicians (2003). Glucocorticoid-induced Osteoporosis. London, UK: RoyalCollege of Physicians of London. ISBN 1-860-16173-1. http://www.rcplondon.ac.uk/pubs/contents/966c62dd-8011-4f65-a61d-dd0c7fe4fa4b.pdf.
^ Gourlay M, Franceschini N, Sheyn Y (2007). "Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures". Clin Rheumatol 26 (2): 144–53. doi:10.1007/s10067-006-0315-1. PMID 16670825.
^ Petty SJ, O'Brien TJ, Wark JD (2007). "Anti-epileptic medication and bone health". Osteoporosis international 18 (2): 129–42. doi:10.1007/s00198-006-0185-z. PMID 17091219.
^ Ruiz-Irastorza G, Khamashta MA, Hughes GR (2002). "Heparin and osteoporosis during pregnancy: 2002 update". Lupus 11 (10): 680–2. doi:10.1191/0961203302lu262oa. PMID 12413068.
^ Gage BF, Birman-Deych E, Radford MJ, Nilasena DS, Binder EF (2006). "Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2". Arch. Intern. Med. 166 (2): 241–6. doi:10.1001/archinte.166.2.241. PMID 16432096. http://archinte.ama-assn.org/cgi/content/full/166/2/241.
^ Yang YX, Lewis JD, Epstein S, MetzDC (2006). "Long-term proton pump inhibitor therapy and risk of hip fracture". JAMA 296: 2947–53. doi:10.1001/jama.296.24.2947. PMID 17190895.
^ Murphy CE, Rodgers PT (2007). "Effects of thiazolidinediones on bone loss and fracture". Ann Pharmacother 41 (12): 2014–8. doi:10.1345/aph.1K286. PMID 17940125.
^ Leib ES, Lewiecki EM, Binkley N, Hamdy RC (2004). "Official positions of the International Society for Clinical Densitometry". J Clin Densitom 7 (1): 1799. doi:10.1385/JCD:7:1:1. PMID 14742881. quoted in: "Diagnosis of osteoporosis in men, premenopausal women, and children"
^ U.S. Preventive Services Task Force (2002). "Screening for osteoporosis in postmenopausal women: recommendations and rationale". Ann. Intern. Med. 137 (6): 526–8. PMID 12230355.
^ Martínez-Aguilà D, Gómez-Vaquero C, Rozadilla A, Romera M, Narváez J, Nolla JM (2007). "Decision rules for selecting women for bone mineral density testing: application in postmenopausal women referred to a bone densitometry unit". J. Rheumatol. 34 (6): 1307–12. PMID 17552058.
^ Schousboe JT, Taylor BC, Fink HA, et al (2007). "Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men". JAMA 298 (6): 629–37. doi:10.1001/jama.298.6.629. PMID 17684185.
^ Frost HM, Thomas CC. Bone Remodeling Dynamics. Springfield, IL: 1963.
^ Lyles KW, Colón-Emeric CS, Magaziner JS, et al (2007). "Zoledronic acid and clinical fractures and mortality after hip fracture". N Engl J Med 357: published online 2007–09–17. doi:10.1056/NEJMoa074941. PMID 17878149.
^ Purcell, P. Boyd, I (2005). "Bisphosphonates and osteonecrosis of the jaw". Medical Journal of Australia 182 (8): 417–418.
^ "6.6.2 Bisphosphonates". British National Formulary (54 ed.). British Medical Association and Royal Pharmaceutical Society of Great Britain. September 2007. pp. p403.
^ Meunier PJ, Roux C, Seeman E, et al (2004). "The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis". N. Engl. J. Med. 350 (5): 459–68. doi:10.1056/NEJMoa022436. PMID 14749454.
^ O'Donnell S, Cranney A, Wells GA, Adachi JD, Reginster JY (2006). "Strontium ranelate for preventing and treating postmenopausal osteoporosis". Cochrane database of systematic reviews (Online) (4): CD005326. doi:10.1002/14651858.CD005326.pub3. PMID 17054253.
^ Reginster JY, Seeman E, De Vernejoul MC, et al (2005). "Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: treatment of peripheral osteoporosis (TROPOS) study.". J Clin Endorinol Metab 90: 2816–22. PMID 15728210.
^ Blake GM, Fogelman I (2007). "The correction of BMD measurements for bone strontium content". J Clin Densitom 10 (3): 259–65. doi:10.1016/j.jocd.2007.03.102. PMID 17543560.
^ Taranta A, Brama M, Teti A, et al (February 2002). "The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro". Bone 30 (2): 368–76. PMID 11856644. http://linkinghub.elsevier.com/retrieve/pii/S8756328201006858.
^ Meunier PJ, Vignot E, Garnero P, et al (1999). "Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene. Raloxifene Study Group". Osteoporos Int 10 (4): 330–6. PMID 10692984. http://link.springer.de/link/service/journals/00198/bibs/9010004/90100330.htm.
^ Meunier PJ, Vignot E, Garnero P, et al (1999). "Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene. Raloxifene Study Group". Osteoporos Int 10 (4): 330–6. PMID 10692984. http://link.springer.de/link/service/journals/00198/bibs/9010004/90100330.htm.
^ "Nutrition and Bone Health". NIAMS. 2005-11-01. http://www.niams.nih.gov/Health_Info/Bone/Bone_Health/Nutrition/default.asp. Retrieved on 2008-01-28.
^ "Calcium & Milk". HarvardSchool of Public Health. 2007. http://www.hsph.harvard.edu/nutritionsource/calcium.html. Retrieved on 2008-01-28.
^ Report of a Joint WHO/FAO/UNU Expert Consultation(2007) Protein and amino acid requirements in human nutrition, pp224-226. ISBN 978-92-4-120935-9
^ Report of a Joint WHO/FAO/UNU Expert Consultation(2002), Human Vitamin and Mineral Requirements, pp166-167.
^ a b Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A (2007). "Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis". Lancet 370 (9588): 657–66. doi:10.1016/S0140-6736(07)61342-7. PMID 17720017.
^ Prince RL, Devine A, Dhaliwal SS, Dick IM (2006). "Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women". Arch. Intern. Med. 166 (8): 869–75. doi:10.1001/archinte.166.8.869. PMID 16636212.
^ Bolland MJ, Barber PA, Doughty RN, et al (2008). "Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial". BMJ 336: 262. doi:10.1136/bmj.39440.525752.BE. PMID 18198394.
^ Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B (2005). "Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials". JAMA 293 (18): 2257–64. doi:10.1001/jama.293.18.2257. PMID 15886381.
^ Jackson RD, LaCroix AZ, Gass M, et al (2006). "Calcium plus vitamin D supplementation and the risk of fractures". N. Engl. J. Med. 354 (7): 669–83. doi:10.1056/NEJMoa055218. PMID 16481635.
^ Bonaiuti D, Shea B, Iovine R, et al (2002). "Exercise for preventing and treating osteoporosis in postmenopausal women". Cochrane database of systematic reviews (Online) (3): CD000333. doi:10.1002/14651858.CD000333. PMID 12137611.
^ Cheng S, Sipilä S, Taaffe DR, Puolakka J, Suominen H (2002). "Change in bone mass distribution induced by hormone replacement therapy and high-impact physical exercise in post-menopausal women". Bone 31 (1): 126–35. doi:10.1016/S8756-3282(02)00794-9. PMID 12110425.
^ Chien MY, WuYT, Hsu AT, Yang RS, Lai JS (2000). "Efficacy of a 24-week aerobic exercise program for osteopenic postmenopausal women". Calcif. Tissue Int. 67 (6): 443–8. doi:10.1007/s002230001180. PMID 11289692.
^ Iwamoto J, Takeda T, Ichimura S (2001). "Effect of exercise training and detraining on bone mineral density in postmenopausal women with osteoporosis". Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 6 (2): 128–32. doi:10.1007/s007760100059. PMID 11484097.
^ Kemmler W, Engelke K, Weineck J, Hensen J, Kalender WA (2003). "The Erlangen Fitness Osteoporosis Prevention Study: a controlled exercise trial in early postmenopausal women with low bone density-first-year results". Archives of physical medicine and rehabilitation 84 (5): 673–82. PMID 12736880.
^ Kerr D, Morton A, Dick I, Prince R (1996). "Exercise effects on bone mass in postmenopausal women are site-specific and load-dependent". J. Bone Miner. Res. 11 (2): 218–25. PMID 8822346.
^ Villareal DT, Binder EF, Yarasheski KE, et al (2003). "Effects of exercise training added to ongoing hormone replacement therapy on bone mineral density in frail elderly women". J Am Geriatr Soc 51 (7): 985–90. doi:10.1046/j.1365-2389.2003.51312.x. PMID 12834519.
^ Sinaki M, Brey RH, Hughes CA, Larson DR, Kaufman KR (2005). "Significant reduction in risk of falls and back pain in osteoporotic-kyphotic women through a Spinal Proprioceptive Extension Exercise Dynamic (SPEED) program". Mayo Clin Proc 80 (7): 849–55. PMID 16007888.
^ Cranney A, Jamal SA, Tsang JF, Josse RG, Leslie WD (2007). "Low bone mineral density and fracture burden in postmenopausal women". CMAJ 177 (6): 575–80. doi:10.1503/cmaj.070234. PMID 17846439.
^ Hannan EL, Magaziner J, Wang JJ, et al (2001). "Mortality and locomotion 6 months after hospitalization for hip fracture: risk factors and risk-adjusted hospital outcomes". JAMA 285 (21): 2736–42. doi:10.1001/jama.285.21.2736. PMID 11386929.
^ Brenneman SK, Barrett-Connor E, Sajjan S, Markson LE, Siris ES (2006). "Impact of recent fracture on health-related quality of life in postmenopausal women". J. Bone Miner. Res. 21 (6): 809–16. doi:10.1359/jbmr.060301. PMID 16753011.
^ a b Riggs, B.L.; Melton, Lj 3.r.d. (2005). "The worldwide problem of osteoporosis: insights afforded by epidemiology.". Bone. PMID 8573428.
^ a b "MerckMedicus Modules: Osteoporosis - Epidemiology". Merck & Co., Inc. http://www.merckmedicus.com/pp/us/hcp/diseasemodules/osteoporosis/epidemiology.jsp. Retrieved on 2008-06-13.
^ Cauley JA, Hochberg MC, Lui LY et al (2007). "Long-term Risk of Incident Vertebral Fractures". JAMA 298: 2761–2767. doi:10.1001/jama.298.23.2761. PMID 18165669.
^ Dalsky GP, StockeKS, Ehsani AA, Slatopolsky E, Lee WC, Birge SJ (1988). "Weight-bearing exercise training and lumbar bone mineral content in postmenopausal women". Ann. Intern. Med. 108 (6): 824–8. PMID 3259410.
^ Feskanich D, Willett WC, Stampfer MJ, ColditzGA (1996). "Protein consumption and bone fractures in women". Am. J. Epidemiol. 143 (5): 472–9. PMID 8610662.
^ Kerstetter JE, O'Brien KO, Insogna KL (2003). "Dietary protein, calcium metabolism, and skeletal homeostasis revisited". Am. J. Clin. Nutr. 78 (3 Suppl): 584S–592S. PMID 12936953.
^ Lobstein JGCFM. Lehrbuch der pathologischen Anatomie. Stuttgart: Bd II, 1835.
^ Albright F, Bloomberg E, Smith PH (1940). "Postmenopausal osteoporosis". Trans. Assoc. Am. Physicians. 55: 298–305.
^ Patlak M (2001). "Bone builders: the discoveries behind preventing and treating osteoporosis". Faseb J. 15 (10): 1677E–E. doi:10.1096/fj.15.10.1677e. PMID 11481214.
^ "About Us", National Osteoporosis Society.
^ "£3million Award Towards The Improvement Of Osteoporosis Services, UK", Medical News Today, 17 March 2008.
http://en.wikipedia.org/wiki/Hypocalcaemia
http://en.wikipedia.org/wiki/Hypercalcaemia
Hurd, Robert (2006-10-25). "Hypoparathyroidism". Medical Encyclopedia. Medline Plus. http://www.nlm.nih.gov/medlineplus/ency/article/000385.htm. Retrieved on 2007-11-02.
· ^ Zink AR, Panzer S, Fesq-Martin M, Burger-Heinrich E, Wahl J, Nerlich AG (2005). "Evidence for a 7000-year-old case of primary hyperparathyroidism". JAMA 293 (1): 40–2. doi:10.1001/jama.293.1.40-c. PMID 15632333.
· ^ Hyperparathyroidism. National Endocrine and Metabolic Diseases Information Service. May 2006.
· ^ "Hyperparathyroidism". Mayo Clinic. May 17, 2007. http://www.mayoclinic.com/health/hyperparathyroidism/DS00396. Retrieved on 2008-01-05.
http://en.wikipedia.org/wiki/Tetany
· ^ Almond CS, Shin AY, Fortescue EB, et al (April 2005). "Hyponatremia among runners in the Boston Marathon". N. Engl. J. Med. 352 (15): 1550–6. doi:10.1056/NEJMoa043901. PMID 15829535.
· ^ "Statement of the Second International Exercise-Associated Hyponatremia Consensus Development Conference 2007" (PDF). http://www.overhydration.org/downloads/EAH_Statement_2008.pdf.
· ^ Siegel AJ, Verbalis JG, Clement S, et al (May 2007). "Hyponatremia in marathon runners due to inappropriate arginine vasopressin secretion". Am. J. Med. 120 (5): 461.e11–7. doi:10.1016/j.amjmed.2006.10.027. PMID 17466660.
· ^ Weisberg LS (March 1989). "Pseudohyponatremia: a reappraisal". Am. J. Med. 86 (3): 315–8. PMID 2645773.
· ^ Nguyen MK, Ornekian V, Butch AW, Kurtz I (May 2007). "A new method for determining plasma water content: application in pseudohyponatremia". Am. J. Physiol. Renal Physiol. 292 (5): F1652–6. doi:10.1152/ajprenal.00493.2006. PMID 17299138.
· ^ Wolff K, Tsapakis EM, WinstockAR, et al (May 2006). "Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population". J. Psychopharmacol. (Oxford) 20 (3): 400–10. doi:10.1177/0269881106061514. PMID 16574714.
· ^ Woman left brain damaged by detox, BBC News, 2008-07-23
· ^ "A Fraternity Hazing Gone Wrong : NPR". http://www.npr.org/templates/story/story.php?storyId=5012154. Retrieved on 2008-05-26.
· ^ "Fallen Officer's Zeal Will Roll On". http://www.washingtonpost.com/wp-dyn/content/article/2005/08/11/AR2005081101924_pf.html. Retrieved on 2008-05-26.
· ^ "Hyponatremia ("Water Intoxication")". The DEA.org. http://thedea.org/hyponatremia.html. Retrieved on 2007-05-10.
· ^ [1]
· ^ "Father's tribute to marathon son". http://news.bbc.co.uk/1/hi/england/london/6587093.stm. Retrieved on 2008-11-05.
^ Perkins RM, Yuan CM, Welch PG (March 2006). "Dipsogenic diabetes insipidus: report of a novel treatment strategy and literature review". Clin. Exp. Nephrol. 10 (1): 63–7. doi:10.1007/s10157-005-0397-0. PMID 16544179. http://dx.doi.org/10.1007/s10157-005-0397-0.
^ Kalelioglu I, Kubat Uzum A, Yildirim A, Ozkan T, Gungor F, Has R (2007). "Transient gestational diabetes insipidus diagnosed in successive pregnancies: review of pathophysiology, diagnosis, treatment, and management of delivery". Pituitary 10 (1): 87–93. doi:10.1007/s11102-007-0006-1. PMID 17308961. http://dx.doi.org/10.1007/s11102-007-0006-1.
The public domain document "Diabetes Insipidus", NIH Publication No. 01-4620, December 2000.
^ "Diabetic ketoacidosis". Diabetic ketoacidosis. Mayo Foundation for Medical Education and Research. 2006. http://www.mayoclinic.com/health/diabetic-ketoacidosis/DS00674/DSECTION=7. Retrieved on 2007-06-15.
^ "Diabetic Coma > Diabetic ketoacidosis". Diabetic ketoacidosis. Armenian Medical Network. 2006. http://www.health.am/db/diabetic-ketoacidosis/. Retrieved on 2007-06-15.
^ "Diabetic ketoacidosis complications". Diabetic ketoacidosis. The Diabetes Monitor. 2007. http://www.diabetesmonitor.com/dmemerh/sld033.htm. Retrieved on 2007-06-15.
^ http://diabetesmanager.pbwiki.com/Hyperglycemic-Crises%253A-Diabetic-Ketoacidosis-%2528DKA%2529%252C-And-Hyperglycemic-Hyperosmolar-State-%2528HHS%2529-
^ Luft, FC (February 2001). "Lactic acidosis update for critical care clinicians". Journal of the American Society of Nephrology (American Society of Nephrology) 12 (Suppl. 17): 15–19. PMID 11251027. http://jasn.asnjournals.org/cgi/content/full/12/suppl_1/S15. Retrieved on 2008-05-28.
^ "Lactic Acidosis retrieved from Access Medicine "Diagnostic Tests"". J Intern Med 2004;255:179. [PMID: 14746555]. http://www.accessmedicine.com. Retrieved on 3/25/09.
^ Woods, Hubert Frank; Cohen, Robert (1976). Clinical and biochemical aspects of lactic acidosis. Oxford: Blackwell Scientific. ISBN 0-632-09460-5.
^ "Lactic Acidosis retrieved from Clinician's Pocket Reference, Chapter 4 via Access Medicine". http://www.accessmedicine.com. Retrieved on 3/25/09.
^ [1]. Accessed 31 January 2009.
Clinical Physiology of Acid-Base and Electrolyte Disorders by Rose, Post
Intensive Care Medicine by Irwin and Rippe
The ICU Book by Marino
· ^ Philip E. Cryer (1997). Hypoglycemia: pathophysiology, diagnosis, and treatment. Oxford [Oxfordshire]: OxfordUniversity Press. ISBN 0-19-511325-X. OCLC 36188385.
· ^ Koh TH, Eyre JA, Aynsley-Green A (1988). "Neonatal hypoglycaemia--the controversy regarding definition". Arch. Dis. Child. 63 (11): 1386–8. PMID 3202648.
· ^ Cornblath M, Schwartz R, Aynsley-Green A, Lloyd JK (1990). "Hypoglycemia in infancy: the need for a rational definition. A Ciba Foundation discussion meeting". Pediatrics 85 (5): 834–7. PMID 2330247.
· ^ Cornblath M, Hawdon JM, Williams AF, Aynsley-Green A, Ward-Platt MP, Schwartz R, Kalhan SC (2000). "Controversies regarding definition of neonatal hypoglycemia: suggested operational thresholds". Pediatrics 105 (5): 1141–5. doi:10.1542/peds.105.5.1141. PMID 10790476.
· ^ a b TustisonWA, Bowen AJ, Crampton JH (1966). "Clinical interpretation of plasma glucose values". Diabetes 15 (11): 775–7. PMID 5924610.
· ^ a b c [edited by] John Bernard Henry (1979). Clinical diagnosis and management by laboratory methods. Philadelphia: Saunders. ISBN 0-7216-4639-5. OCLC 4884633.
· ^ Clarke WL, Cox D, Gonder-Frederick LA, Carter W, Pohl SL (1987). "Evaluating clinical accuracy of systems for self-monitoring of blood glucose". Diabetes Care 10 (5): 622–8. doi:10.2337/diacare.10.5.622. PMID 3677983.
· ^ Gama R, Anderson NR, Marks V (2000). "'Glucose meter hypoglycaemia': often a non-disease". Ann. Clin. Biochem. 37 ( Pt 5): 731–2. doi:10.1258/0004563001899825. PMID 11026531.
· ^ de Pasqua A, Mattock MB, Phillips R, Keen H (1984). "Errors in blood glucose determination". Lancet 2 (8412): 1165. PMID 6150231.
· ^ Horwitz DL (1989). "Factitious and artifactual hypoglycemia". Endocrinol. Metab. Clin. North Am. 18 (1): 203–10. PMID 2645127.
· ^ Samuel Meites, editor-in-chief; contributing editors, Gregory J. Buffone... [et al.] (1989). Pediatric clinical chemistry: reference (normal) values. Washington, D.C: AACC Press. ISBN 0-915274-47-7. OCLC 18497532.
· ^ 20 White NH, Skor D, Cryer PE, Bier DM, Levandoski L, Santiago JV: Identification of type 1 diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med 308:485–491, 1983
· ^ 21 Bolli GB, De Feo P, De Cosmo S, Perriello G, Ventura MM, Massi-Benedetti M, Santeusanio F, Gerich JE, Brunetti P: A reliable and reproducible test for adequate glucose counterregulation in type 1 diabetes. Diabetes 33:732–737, 1984
· ^ edited by Allen I. Arieff, Robert C. Griggs (1992). Metabolic brain dysfunction in systemic disorders. Boston: Little, Brown. ISBN 0-316-05067-9. OCLC 24912204.
· ^ http://ajpendo.physiology.org/cgi/content/full/283/2/E207
· ^ http://jcem.endojournals.org/cgi/content/full/89/9/4450
· ^ "The Hypoglycemic states - Hypoglycemia". The Hypoglycemic states. Armenian Medical Network. 2007. http://www.health.am/db/the-hypoglycemic-states-hypoglycemia/.
· ^ Addison disease at Dorland's Medical Dictionary
· ^ Thomas Addison (HTML reprint). On The Constitutional And Local Effects Of Disease Of The Supra-Renal Capsules. London: Samuel Highley. http://www.wehner.org/addison/x1.htm.
· ^ a b c d e f g h i j Ten S, New M, Maclaren N (2001). "Clinical review 130: Addison's disease 2001". J. Clin. Endocrinol. Metab. 86 (7): 2909–22. doi:10.1210/jc.86.7.2909. PMID 11443143. http://jcem.endojournals.org/cgi/content/full/86/7/2909.
· ^ Patnaik MM, DeshpandeAK (May 2008). "Diagnosis--Addison's disease secondary to tuberculosis of the adrenal glands". Clin Med Res 6 (1): 29. doi:10.3121/cmr.2007.754a. PMID 18591375. PMC: 2442022. http://www.clinmedres.org/cgi/pmidlookup?view=long&pmid=18591375.
· ^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0721629210.
· ^ Addison's Disease National Endocrine and Metabolic Diseases Information Service. Retrieved on 26 October 2007.
· ^ Wang L, Yang J (2008). "Tuberculous Addison's disease mimics malignancy in FDG-PET images". Intern. Med. 47 (19): 1755–6. doi:10.2169/internalmedicine.47.1348. PMID 18827432. http://joi.jlc.jst.go.jp/JST.JSTAGE/internalmedicine/47.1348?from=PubMed.
· ^ "Addison Disease � Health information regarding this hormonal (endocrine) disorder on MedicineNet.com". http://www.medicinenet.com/addison_disease/article.htm. Retrieved on 2007-07-25.
· ^ a b "eMedicine - Addison Disease : Article by Sylvester Odeke". http://www.emedicine.com/med/topic42.htm. Retrieved on 2007-07-25.
· ^ "medhelp". http://www.medhelp.org/www/nadf3.htm. Retrieved on 2007-07-25.
· ^ Volpé, Robert (1990). Autoimmune Diseases of the Endocrine System. CRC Press. pp. 299. ISBN 0849368499.
· ^ "Dog Days Of Science". http://grants.nih.gov/grants/policy/air/dog_days.htm. Retrieved on 2008-09-01.
· ^ Nicholas JA, Burstein CL, Umberger CJ, Wilson PD (November 1955). "Management of adrenocortical insufficiency during surgery". AMA Arch Surg 71 (5): 737–42. PMID 13268224.
· ^ Owen, David (May 2003). "Diseased, demented, depressed: serious illness in Heads of State". QJM: An International Journal of Medicine (Oxford University Press) 96 (5): 325–36. doi:10.1093/qjmed/hcg061. PMID 12702781. http://qjmed.oxfordjournals.org/cgi/content/full/96/5/325.
· ^ "The Australian Addison's Disease Association". http://www.addisons.org.au/core.htm?page=/awareness/awarenessweek.htm. Retrieved on 2007-07-25.
· ^ Marsden, Brian (1997-07-18). "Eugene Shoemaker (1928-1997)" (HTML). Comet Shoemaker-Levy Collision with Jupiter. Jet Propulsion Laboratory. http://www2.jpl.nasa.gov/sl9/news81.html. Retrieved on 2007-07-25.
· ^ Jones, Terry. "Patron Saints Index: Blessed Elizabeth of the Trinity". http://saints.sqpn.com/sainte46.htm. Retrieved on 2008-05-04.
· ^ Upfal, Annette (2005). "Jane Austen’s lifelong health problems and final illness: New evidence points to a fatal Hodgkin’s disease and excludes the widely accepted Addison's". Medical Humanities (BMJ Publishing Group Ltd) 31: 3–11. doi:10.1136/jmh.2004.000193. http://mh.bmj.com/cgi/content/full/31/1/3.
· ^ L. Williams et al. (1991). "The Nineteenth Century: Victorian Period". The Year's Work in English Studies (Oxford University Press) 72 (1): pp. 314–360. doi:10.1093/ywes/72.1.314. http://ywes.oxfordjournals.org/cgi/content/long/72/1/314.
· ^ Wright, Lawrence (2006). The Looming Tower. New York City: Alfred A. Knopf, Inc. p. 139. ISBN 978-0375414862.
^ myxedema at Dorland's Medical Dictionary
^ "Pretibial Myxedema", Retrieved on 2009-3-27
^ "Hasihimotos Thyroiditis", Retrieved on 2009-3-27
http://en.wikipedia.org/wiki/Hypercalcaemia
· ^ Faculty of Medicine & Dentistry (2006). "Course-Based Physical Examination - Endocrinology -- Endocrinology Objectives (Thyroid Exam)". Undergraduate Medical Education. University of Alberta. http://www.med.ualberta.ca/education/ugme/clinicaled12/clinskills_endocrinology.cfm?yr=1. Retrieved on 2007-01-28.
· ^ Geffner, DL, Hershman, JM.ß-adrenergic blockade for the treatment of hyperthyroidism. Am J Med 1992; 93:61.
· ^ Berglund J, Christensen SB, Dymling JF, Hallengren B (1991). "The incidence of recurrence and hypothyroidism following treatment with antithyroid drugs, surgery or radioiodine in all patients with thyrotoxicosis in Malmö during the period 1970-1974". J. Intern. Med. 229 (5): 435–42. PMID 1710255.
· ^ Esfahani AF, Kakhki VR, Fallahi B, et al (2005). "Comparative evaluation of two fixed doses of 185 and 370 MBq 131I, for the treatment of Graves' disease resistant to antithyroid drugs". Hellenic journal of nuclear medicine 8 (3): 158–61. PMID 16390021.
· ^ Markovic V, Eterovic D (2007). "Thyroid echogenicity predicts outcome of radioiodine therapy in patients with Graves' disease". J. Clin. Endocrinol. Metab. 92 (9): 3547–52. doi:10.1210/jc.2007-0879. PMID 17609305.
· ^ http://www.thyroid-info.com/articles/cat-hyper.htm
· ^ Susan Little (2006). "Feline Hyperthyroidism" (PDF). Winn Feline Foundation. http://www.winnfelinehealth.org/Pages/Feline_Hyperthyroidism_Web.pdf. Retrieved on 2007-01-28.